Abstract
The synthesis of various substituted bicyclic lactams by an acid-induced Pictet-Spengler reaction of tetrahydroindolinones bearing tethered heteroaromatic rings is presented. The outcome of the cyclization depends on the position of the furan tether, tether length, nature of the tethered heteroaromatic ring and the substituent group present on the 5-position of the tethered heteroaryl group. A one-pot procedure was developed to efficiently prepare tetrahydroindolinones containing tethered furan rings. In a typical example, the reaction of furanyl azide 26 with n-Bu3P delivered iminophosphorane 27, which was allowed to react with a 1 -alkyl-(2-oxocyclohexyl)acetic acid to provide the desired furanyl substituted tetrahydroindolinone system 29. Treatment of 29 with trifluoroacetic acid afforded the tetracyclic lactam skeleton 30 found in the alkaloid (±)-selaginoidine.
Introduction
The Pictet-Spengler reaction corresponds to an acid-catalyzed intramolecular cyclization of a 2-arylethylimine.1–3 This process is routinely used for the synthesis of tetrahydroisoquinolines and tetrahydro-β-carboline ring systems, which are present in numerous natural and synthetic organic compounds possessing biological activity.4 Although the Pictet-Spengler reaction has long been believed to require electron-rich aromatics such as indoles or aryl rings substituted with strongly electron-donating substituents such as hydroxy or alkoxy groups,5 superacid catalysts do enable the cyclization of unactivated imines of type 1 to give 1 -substituted 1,2,3,4-tetrahydroisoquinolines 2.6 A number of diastereoselective substrate-controlled Pictet-Spengler cyclizations have also been developed leading to useful chiral building blocks for alkaloid synthesis.7 Recently, Jacobsen8 and List9 have independently reported examples of highly enantioselective catalytic Pictet-Spengler reactions providing ready access to a range of substituted tetrahydro-β-carbolines in high enantiomeric excess.
In an earlier report from our laboratory, we described a convenient synthesis of variously substituted octahydroindolo[7a,1a]isoquinolines by an acid-induced Pictet-Spengler reaction of tetrahydroindolinones bearing tethered phenethyl groups (Scheme 2).10 A related NBS-promoted intramolecular electrophilic aromatic substitution reaction of 1 -[2-(3,4-dimethoxyphenyl)ethyl]-1,4,5,6-tetrahydroindolinone (3b) was also used to assemble the tetracyclic core of the erythrinone skeleton. The resulting cyclized product 5 was transformed into the erythrina alkaloid (±)-erysotramidine (6) in three additional steps.
Scheme 2.
NBS Promoted Cyclization Reaction
The erythrina and related homoerythrina family of alkaloids constitute a large class of structurally diverse natural products that have received considerable attention over the past few decades.11 Members of the erythrina and homoerythrina family possess curare-like activity, and the alkaloidal extracts have been used extensively in indigenous medicine.12 Each of these alkaloid groups are generally classified into two sets according to their structural features,13 those whose D-rings are aromatic (e.g. 3-demethoxyerythratidinone (7) and schelhammerine (8)) and the others whose D-rings are nonbenzenoid (e.g. phellibiline (9) and selaginoidine (10)).14 Many different approaches have been employed for the synthesis of these alkaloids.15–17
On the basis of our earlier studies,10 we felt that a Pictet-Spengler reaction of a suitably substituted tetrahydroindolinone precursor might allow for a facile entry to the tetracyclic core of selaginoidine (10), a unique homoerythrina nonbenzenoid alkaloid isolated from the taxodeaceous plant Athrotaxis selaginoides.18 The formation of the homoerythrina skeleton of 10 was envisioned to come about from a Pictet-Spengler cyclization of furanyl tetrahydroindolinone 11. A convenient way to construct 11 would involve condensation of an appropriate furanyl amine such as 13 with a 1-substituted-(2-oxocyclohexyl)acetic acid derivative (i.e., 12) under Dean-Stark conditions (Scheme 3). In this paper, we describe an account of our efforts to synthesize the homoerythrina skeleton using the Pictet-Spengler cyclization of tetrahydroindolinones containing tethered heteroaromatic rings.
Scheme 3.
Retrosynthetic Analysis Toward Selaginoidine (10)
Results and Discussion
As a prelude to the synthesis of selaginoidine (10), we first set out to evaluate the Pictet-Spengler reaction of several tetrahydroindolinones containing tethered furans in order to test the viability of our design as well as to determine the scope and generality of the cyclization. With this in mind, we first studied the cyclization of tetrahydroindolinone 16.19 Condensation of (1-methyl-2-oxocyclohexyl)acetic acid (14) with 2-furan-2-ylethylamine (15) under Dean-Stark conditions in xylene at 160 °C for 1 h afforded the desired bicyclic lactam 16 in 65% yield. Treatment of 16 with trifluoroacetic acid produced the tetracyclic substituted lactam 18 in 78% yield (Scheme 4). The formation of a single lactam diastereomer is the result of the stereoelectronic preference for axial attack by the furan ring on the N-acyliminium ion 1720 from the least hindered side.21 This cyclization is especially noteworthy considering that none of the previously reported syntheses of the nonbenzenoid erythrina class of alkaloids have employed this strategy of assemblage.22
Scheme 4.
Mechanism of the Acid Promoted Cyclization
To demonstrate that this methodology could also be used for β-phenethylamine pharmacophores23 possessing the homoerythrina skeleton, the homologous furan 19 (n=2) was treated with keto acid 14 and the resulting tetrahydroindolinone 20 was subjected to the acid-catalyzed cyclization conditions (Scheme 5). Interestingly, the only product isolated in 54% yield corresponded to the novel dimeric furanyl bis-lactam 21 which is derived by bimolecular trapping of the N-acyliminium ion at the more activated 5-position of the furan ring.
Scheme 5.
Dimer Formation Using an Unsubstitued Furan
At this point we reasoned that by incorporating a substituent at the 5-position of the furan ring we would be able to suppress the undesired dimerization reaction. With this in mind, we prepared tetrahydroindolinone 24 containing a methyl group at the 5-position of the furan ring by the condensation of 3-(5-methyl-furan-2-yl)propan-1-amine (22) with benzyl 1-(2-ethoxy-2-oxoethyl)-2-oxocyclo-hexanecarboxylate (23) which gave 24 in 62% yield. Gratifyingly, the reaction of 24 with TFA at 25 °C afforded bicyclic lactam 25 in 95% yield, where cyclization now occurred at the 3-position of the furan ring as a consequence of the presence of the methyl group which blocks the dimerization pathway (Scheme 6).
Scheme 6.
Seven-Membered Ring Skeleton
We also investigated the acid catalyzed cyclization of the related tetrahydroindolinone 29. Our first attempts to synthesize 29 involved the reaction of 2-(3-aminopropyl)-5-ethylfuran with ketoacid 14. In our hands, the reduction of azides such as 26 to the required primary amine sometimes proved to be problematic. Likewise, the Staudinger reaction24 using the iminophosphorane 27 derived from azide 26 also proved troublesome, as we could only obtain the corresponding amine as an impure oil in low yield. Iminophosphoranes were first prepared at the beginning of the last century by Staudinger and have become extremely useful reagents for the construction of nitrogen containing heterocycles.24 The aza-Wittig reaction corresponds to the nitrogen analogue of the Wittig olefination process and involves the reaction of an iminophosphorane with a carbonyl group. The reaction has been used to prepare various imines and its synthetic relevance has been summarized in several review articles.25 The intramolecular version of this reaction has drawn considerable attention in recent years because of its high potential for heterocyclic synthesis.26 Since we were having some difficulty converting azide 26 into the corresponding amine for subsequent condensation with ketoacid 14, we wondered whether it might be possible to use azide 26 directly without the intervention of the amine. Thus, an aza-Wittig type reaction of iminophosphorane 27 with ketoacid 14 should generate 28, which could be expected to rapidly cyclize and furnish the desired tetrahydroindolinone system 29 (Scheme 7). Indeed, this proved to be the case, especially when microwave technology was applied to the condensation reaction. Treating a sample of 29 with trifluoroacetic acid afforded bicyclic lactam 30 in 96% yield. In this case cyclization occurred at the 3-position of the furan ring, again as a consequence of the presence of the ethyl group, which blocks the dimerization route. Thus, by using this methodology we were able to construct the seven-membered C ring of model compounds 25 and 30 which contain the required tetracyclic furan-type skeleton of selaginoidine (10).
Scheme 7.
Use of Iminophosphoranes for the Synthesis of Tetrahydroindolinones
A series of additional experiments showed that this electrophilic-induced cyclization succeeds with a variety of substrates containing tethered heteroaromatic rings. Thus, we were pleased to find that the analogous (3-furan-2-yl)ethyl substituted tetrahydroindolinone 31 also underwent a related acid-induced cyclization to give the tetracyclic substituted lactam 32 in 98% yield (Scheme 8). As all of the previous examples involved furanyl π-bond cyclizations, we decided to study several tetrahydroindolinones which contain other tethered five-ring heterocycles. We found that treatment of the thiophen-3-yl substituted system 33 with trifluoroacetic acid at 25 °C for 4 h afforded the closely related tetracyclic lactam 34 in 73% yield (Scheme 8). However, in order to induce cyclization of the isomeric thiophen-2-yl substituted system 35, it was necessary to heat this compound at 90 °C using polyphosphoric acid as solvent for 12 h and the resulting product 36 was only isolated in 33% yield. As is the case with other five-membered heterocycles, electrophilic substitution at the 2-position of the ring is strongly favored over the 3-position and this factor nicely accommodates the marked difference in the rate of cyclization of 33 vs. 35. Annulative ring cyclization of the pyrrolo-2-yl substituted system also occurred producing the tetracyclic lactam 38 in 70% yield. In this case, it was not possible to isolate tetrahydroindolinone 37 as it rapidly cyclized to 38 under the conditions used for its preparation.
Scheme 8.
Acid-Promoted Cyclization of Various Heteroaromatic Systems
Related cyclization reactions were also observed to occur with the analogous indolyl substituted amines 39 and 41 (Scheme 9). The cyclized products 40 and 42 were easily obtained from the condensation of keto acid 14 with either of the primary indolylamines. The condensation reaction was best carried out under microwave conditions at 180 °C. The expected tetrahydroindolinones were not detected as they readily underwent cyclization to give the tetracyclic lactams 40 and 42 in 85% and 90% yield, respectively. These two additional examples nicely demonstrate the facility with which the acid-induced cyclization cascade occurs using a variety of cyclic enamido lactams containing tethered heteroaromatic rings.
Scheme 9.
Cyclization of Indolyl Substituted Systems
Earlier work in our laboratory has shown that the Pummerer reaction followed by a π-cyclization represents an effective and general method for the preparation of many diverse aza-polycyclic skeletons.27 Since the combination of a Pummerer/Mannich cyclization sequence offers unique opportunities for the assemblage of complex target molecules,28 we decided to study the acid-induced cyclization of enamides 46 (n=1) and 47 (n=2) to determine whether these systems could also be used to assemble the core skeleton of the erythrina/homoerythrina family of alkaloids. Furanyl azide 43 was easily converted into the desired enamide sulfide (i.e., 44) following the azide/iminophosphorane/ethylthioacetyl chloride protocol already established (Scheme 10). A subsequent sodium periodate oxidation afforded sulfoxide 46, which on treatment with trifluoroacetic anhydride in the presence of trifluoroacetic acid furnished the tetracyclic lactam 48 in 76% yield as the exclusive product. The preferential formation of 48 is consistent with our earlier stereochemical observations,29 suggesting that a 4π-Nazarov type electrocyclization30 controls the direction of closure from the α-acylthionium ion intermediate. The Pictet-Spengler step involves attack of the proximal furanyl ring from the less hindered side of the iminium ion.
Scheme 10.
Pummerer/Mannich Cyclizations
To demonstrate that this methodology could also be used for assembling the homoerythrina skeleton, the homologous furanyl sulfoxide 47 was subjected to the acid catalyzed cyclization conditions (Scheme 10). The major product isolated (40%) corresponded to the cyclized lactam 49. Presumably, the lower yield of product is related to the entropically more demanding seven-membered ring cyclization onto the resulting N-acyliminium ion formed from the initial Pummerer reaction. We also attempted to prepare the simpler seven-membered tetracyclic lactam 52 by subjecting sulfoxide 50 to the Pummerer cyclization conditions. Our hope was that it would be possible to induce a tandem Pummerer/N-acyliminium ion cascade and convert 50 directly into 52 as shown in Scheme 11. Toward this end, a sample of 50 was heated in benzene in the presence of 10-camphorsulfonic acid and this resulted in the formation of the Pummerer cyclized lactam 51 in 70% yield. Unfortunately, all of our further efforts to prepare 52 from 51 only provided a complex mixture of products and we eventually had to abandon further cyclization studies with this system.
Scheme 11.
A Failed Pummerer/N-Acyliminium ion Cascade
An alternative approach that we explored in an attempt to form the key seven-membered ring of selaginoidine (10) was to use either a Heck or radical-induced cyclization of a model 3-bromo-furanyl substituted tetrahydroindoline such as 56. The synthesis of 56 was carried out by reacting azide 53 with tributylphosphine at 25 °C. Addition of ketoacid 14 to iminophosphorane 54 followed by mircrowave irradiation gave the desired enamido lactam 56 in 63% yield presumably via the intermediacy of imine 55 (Scheme 12). Unfortunately, all of our efforts to induce either a Heck or radical cyclization of 56 failed to produce the desired product and only dark tarry oils were obtained. Despite our best efforts to vary the experimental conditions, no detectable quantities of a cyclized product derived from 56 could be obtained.
Scheme 12.
Synthesis of a Bromo Substituted Tetrahydroindolinone
Since the Heck/radical cyclization route proved to be unfeasible, we decided to reexamine the acid-catalyzed cyclization of our model system (i.e., 24). The simplest readjustment would be to add a 1,3-dioxolanyl group at the 5-position of the tetrahydroindolinone ring. In fact, this addition would create a more accurate model system (i.e., 58), since the target homoerythrina alkaloid selaginoidine possesses a methoxy substituent at the 10-position of the A-ring which we assumed could eventually be derived from the ketal group located at the C(11) carbon atom. The retrosynthetic plan we had in mind is outlined in Scheme 13. To this end, keto ester 57 was prepared and condensed with furanyl amine 22 to provide tetrahydroindolinone 58 in 80% yield. With the bicyclic system now functionalized, we explored the conversion of 58 into 59. However, all of our efforts to achieve this cyclization using a variety of acidic conditions failed. Repeated trials simply resulted in the hydrolysis of the ketal functionality to the corresponding ketone 61 or else gave rise to the ring opened 1,4-dione 60 derived from hydrolysis of the furan ring.
Scheme 13.
Tetrahydroindolinone Containing a 1,3-Dioxolanyl Group
The problem with this approach appears to be that generation of the required N-acyliminium ion by protonation of 58 was simply too slow relative to the hydrolysis of either the ketal or furanyl functionalities. Based on the knowledge that hydroxy amides such as 64 are more reactive towards protonation than enamides of type 58,20 we next examined the TFA promoted cyclization of bicyclic lactam 64. As shown in Scheme 14, our synthesis of 64 starts by treating 1,4-dioxaspiro[4.5]decan-8-one (62) with LDA at −78 °C in THF and allowing the resulting enolate to react with 2-iodo-N-(3-(5-methylfuran-2-yl)propyl)acetamide (63). The expected C-alkylation reaction occurred smoothly and gave 64 in 80% yield. The reaction of 64 with 2 equiv of TFA in CH2Cl2 at 25 °C afforded the desired homoerythrina compound 65 in 75% yield which possesses a structure closely related to that of selaginoidine 10.31 Further studies using this methodology toward selaginoidine are currently underway and will be described at a future date.
Scheme 14.
Successful Cyclization Leading to the Homoerythrina Skeleton
In conclusion, we have developed a general and efficient strategy for the synthesis of the seven-membered ring skeleton found in selaginoidine. A variety of vinylogous amides and tetrahydroindolinones can be prepared using an aza-Wittig reaction of iminophosphoranes derived from furanyl azides and 1-alkyl-(2-oxocyclohexyl)acetic acids. Intramolecular electrophilic substitution on the furan ring occurs when the tetrahydroindolinone is treated with acid leading to both the six and seven membered C-ring of the erythrina and homoerythrina skeleton. The application of this approach toward other natural product targets is currently under investigation, the results of which will be disclosed in due course.
Experimental Section
1-(2-Furan-2-yl-ethyl)-3a-methyl-1,3,3a,4,5,6-hexahydroindol-2-one (16) was prepared in 65% yield from (1-methyl-2-oxo-cyclohexyl)acetic acid32 (14) and 2-furan-2-yl-ethylamine33; IR (thin film) 2933, 2860, 1674, 1449, and 1072 cm−1; 1H-NMR (400 MHz, CDCl3) δ 1.12 (s, 3H), 1.51 (m, 1H), 1.73–1.77 (m, 3H), 2.10–2.23 (m, 4H), 2.87 (t, 2H, J = 7.2 Hz), 2.87 (m, 1H), 3.93 (m, 1H), 4.77 (t, 1H, J = 3.2 Hz), 6.06 (t, 1H, J= 2.4 Hz), 6.26 (t, 1H, J= 2.0 Hz), and 7.30 (t, 1H, J= 1.2 Hz); 13C-NMR (100 MHz, CDCl3) δ 18.5, 22.8, 25.6, 26.1, 34.1, 36.3, 37.9, 46.4, 97.3, 106.5, 110.4, 141.5, 145.4, 152.7, and 173.8; HRMS Calcd. for C15H19NO2: 245.1416. Found: 245.1411.
8-Methyl-8,8a-cyclohexyl-4,7,8,8a-tetrahydro-5H-3-oxa-5a-aza-as-indacen-6-one (18)
To a solution of 0.31 g (1.3 mmol) of hexahydroindolone 16 in 13 mL of CH2Cl2 was added trifluoroacetic acid (0.3 mL, 3.8 mmol). The mixture was stirred at rt for 4 h and the solvent was removed under reduced pressure. The crude product was purified by flash chromatography on silica gel to give 18 as a colorless oil in 78% yield; IR (thin film) 2931, 2861, 1687, 1452, 1416, and 1327 cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.72 (s, 3H), 1.47–1.58 (m, 4H), 1.71–1.78 (m, 3H), 1.90 (d, 1H, J= 16.4 Hz), 2.10 (m, 1H), 2.70 (m, 2H), 2.79 (d, 1H, J= 16.4 Hz), 3.01 (dddd, 1H, J= 24.4, 11.2, 6.0 and 1.6 Hz), 4.38 (ddd, 1H, J= 12.6, 6.0 and 1.6 Hz), 6.38 (d, 1H, J= 1.6 Hz), and 7.30 (d, 1H, J= 1.6 Hz); 13C-NMR (100 MHz, CDCl3) δ 21.9, 22.1, 23.4, 26.5, 33.7, 33.8, 36.5, 40.2, 42.1, 63.9, 108.5, 119.9, 141.3, 147.8, and 172.3; HRMS Calcd. for C15H19NO2: 245.1416. Found: 245.1406.
1 -(3-Furan-2-yl-propyl)-3a-methyl-1,3,3a,4,5,6-hexahydroindol-2-one (20) was prepared in 81% yield from keto acid 14 and 3-furan-2-yl-propylamine34; IR (thin film) 2935, 2860, 1674, 1445, and 1309 cm−1;1H-NMR (400 MHz, CDCl3) δ 1.17 (s, 3H), 1.52 (m, 1H), 1.72–1.93 (m, 5H), 2.01–2.23 (m, 2H), 2.25 (s, 2H), 2.63 (t, 2H, J = 10.2 Hz), 3.23 (ddd, 1H, J= 18.2, 10.0 and 7.6 Hz), 3.67 (dt, 1H, J= 18.8 and 10.0 Hz), 4.74 (t, 1H, J= 5.0 Hz), 6.01 (dd, 1H, J= 4.2 and 1.0 Hz), 6.27 (dd, 1H, J = 4.2 and 2.6 Hz), and 7.29 (dd, 1H, J= 2.6 and 1.0 Hz); 13C-NMR (100 MHz, CDCl3) δ 18.6, 22.8, 25.5, 25.7, 26.3, 34.1, 36.4, 38.7, 46.5, 97.3, 105.3, 110.3, 141.1, 145.8, 155.3, and 174.0; HRMS Calcd. for C16H21NO2: 259.1572. Found: 259.1567.
Acid Induced Dimerization of Hexahydroindolinone 20
To a solution of 0.05 g (0.16 mmol) of hexahydroindolone 20 in 3 mL of CH2Cl2 was added trifluoroacetic acid (0.04 mL, 0.5 mmol). The mixture was stirred at rt for 4 h and then the solvent was removed under reduced pressure. The crude product was purified by flash chromatography to give dimer 21 as a white crystalline solid in 54% yield; mp 266–270 °C; IR (KBr) 1686, 1398, 1208, and 1145 cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.8 (s, 6H), 1.20–1.53 (m, 12H), 1.61 (dd, 2H, J= 10.4 and 4.0 Hz), 1.93 (m, 4H), 2.01 (d, 4H, J= 16.0 Hz), 2.34 (dt, 2H, 14.4 and 8.0 Hz), 2.42 (d, 2H, J= 16.0 Hz), 2.58 (dt, 2H, J= 14.4 and 6.0), 2.74 (ddd, 2H, J= 15.6, 10.0, and 5.6 Hz), 3.16 (m, 2H), 5.95 (d, 2H J= 3.0 Hz), and 6.02 (d, 2H, J= 3.0 Hz); 13C-NMR (100 MHz, CDCl3) δ 21.7, 21.8, 26.0, 28.0, 28.7, 37.0, 40.2, 40.6, 45.8, 67.8, 106.6, 109.3, 153.9, 155.2, and 177.2; HRMS Calcd. for C32H42N2O4: 518.3144. Found: 518.3133.
Benzyl 1-(2-ethoxy-2-oxoethyl)-2-oxocyclohexanecarboxylate
To a stirred solution of 0.21 g (5.2 mmol) of NaH (60% in mineral oil) in 15 mL of THF at 0 °C was added a solution of 1 g (4.3 mmol) of benzyl 2-oxocyclohexanecarboxylate35 in 5 mL of THF. The reaction mixture was stirred for 30 min at 0 °C and then 0.8 mL (4.4 mmol) of HMPA was added, followed by the dropwise addition of 0.7 mL (6.5 mmol) of ethyl bromoacetate. The resulting solution was stirred for 4 h at 0 °C and then a saturated NH4Cl solution was added and the mixture was extracted with ether. The organic layer was dried over MgSO4, filtered and concentrated under reduced pressure. The crude mixture was subjected to flash silica gel chromatography to give 0.97 g (71%) of the titled compound as a colorless oil; IR (thin film) 2935, 1747, 1706, 1455, 1189 and 748 cm−1; 1H-NMR (CDCl3, 400 MHz) δ 1.17 (t, 3H, J= 7.2 Hz), 1.56–1.74 (m, 4H), 1.93–1.99 (m, 1H), 2.39–2.43 (m, 2H), 2.61–2.69 (m, 1H), 2.70 (s, 2H), 4.04 (qd, 2H, J= 7.0 and 1.2 Hz), 5.12 (d, 1H, J = 12.2 Hz), 5.18 (d, 1H, J= 12.2 Hz) and 7.27–7.32 (m, 5H); 13C-NMR (100 MHz, CDCl3) δ 14.1, 22.0, 27.0, 36.7, 39.8, 40.5, 58.9, 60.6, 67.3, 128.3, 128.4, 128.6, 135.4, 170.8, 171.3 and 206.6.
Benzyl 1-(3-(5-methylfuran-2-yl)propyl)-2-oxo-2,3,3a,4,5,6-hexahydro-1H-indole-3a-carboxylate (24)
To a solution of 0.32 g (1.0 mmol) of the above compound in 3 mL of xylene in a microwave tube was added 0.16 g (1.1 mmol) of 3-(5-methylfuran-2-yl)propan-1-amine (22).36 The tube was sealed and the mixture was heated under microwave irradiation for 20 min at 180 °C. At the end of this time, the reaction mixture was subjected to flash silica gel chromatography to give 0.24 g (62%) of tetrahydroindolinone 24 as a pale yellow oil; IR (thin film) 1728, 1686, 1451, 1399, 1315, 1277, 1188 and 779 cm−1;1H-NMR (CDCl3, 300 MHz) δ 1.43–1.62 (m, 2H), 1.70–1.93 (m, 3H), 2.03–2.18 (m, 1H), 2.22 (s, 3H), 2.41 (d, 1H, J= 16.5 Hz), 2.45–2.57 (m, 4H), 2.72 (d, 1H, J=16.5 Hz), 3.21 (ddd, 1H, J= 14.1, 7.8 and 5.7 Hz), 3.72 (dt, 1H, J= 13.8 and 7.5 Hz), 4.94 (t, 1H, J= 3.6 Hz), 5.10 (s, 2H), 5.82 (s, 2H) and 7.25–7.32 (m, 5H); 13C-NMR (75 MHz, CDCl3) δ 13.7, 19.6, 22.7, 25.3, 25.6, 31.3, 39.1, 42.0, 47.9, 67.2, 100.1, 105.8, 105.9, 128.1, 128.4, 128.6, 135.5, 139.5, 150.3, 153.2, 172.0 and 173.4; HRMS Calcd. for C24H27NO4 [M+H+]: 394.2040. Found: 394.2033.
1,2-Furanyl Fused Benzyl 7-Oxododecahydroazepino[1,2-i]indole-8a-carboxylate (25)
To a solution of 0.1 g (0.25 mmol) of the above tetrahydro-indolone 24 in 5 mL of CH2Cl2 was added trifluoroacetic acid (80 μL, 1.0 mmol). The mixture was stirred at rt for 24 h and the solvent was then removed under reduced pressure. The crude residue was purified by flash chromatography on silica gel to give 0.09 g (95%) of 25 as a clear oil; IR (thin film) 1730, 1702, 1439, 1402, 1228, 1158 and 732 cm−1; 1H-NMR (CDCl3, 400 MHz) δ 1.20–1.34 (m, 2H), 1.51–1.79 (m, 3H), 1.84–1.95 (m, 3H), 1.99–2.03 (m, 1H), 2.05 (s, 3H), 2.14–2.23 (m, 2H), 2.55–2.58 (m, 2H), 2.85–2.93 (m, 2H), 4.27 (dt, 1H, J= 14.2 and 8.0 Hz), 5.08 (d, 1H, J= 12.4 Hz), 5.16 (d, 1H, J= 12.4 Hz), 5.58 (d, 1H, J= 0.8 Hz) and 7.28–7.37 (m, 5H); 13C-NMR (100 MHz, CDCl3) δ 13.6, 20.9, 21.0, 24.7, 26.5, 31.8, 32.8, 37.1, 40.9, 50.4, 64.9, 66.9, 106.2, 123.7, 128.4, 128.5, 128.8, 135.5, 149.4, 151.9, 173.1 and 174.7; HRMS Calcd. for C24H27NO4[M+H+]: 394.2018. Found: 394.2013.
2-(3-Azidopropyl)-5-ethyl-furan (26)
To a solution of 0.45 g (2.9 mmol) of 1-hydroxy-non-5-yn-4-one37 in 7 mL of N,N-dimethylacetamide in a sealed tube was added 29 mg (0.15 mmol) of copper (I) iodide followed by 0.9 mL of triethylamine. The vessel was sealed and the mixture was heated at 100 °C for 24 h. After cooling to 25 °C, water was added and the solution was extracted with ether and dried over sodium carbonate. The solution was concentrated under reduced pressure and the resulting furanyl alcohol was immediately used in the next step.38
The above alcohol was dissolved in 10 mL of CH2Cl2 at 0 °C and 0.3 g (2.7 mmol) of methanesulfonyl chloride was added followed by 0.6 g (6.2 mmol) of triethylamine. After warming to room temperature over 30 min, the reaction mixture was quenched with water and extracted with CH2Cl2. The extracts were dried over MgSO4 and concentrated under reduced pressure. The crude mesylate was dried using a vacuum pump before being dissolved in 5 mL of DMF. Sodium azide (0.3 g, 5 mmol) was added and the solution was stirred for 15 h at 50 °C. To the mixture was added water and the solution was extracted with ether and the combined ether extracts were washed with brine, dried over MgSO4 and concentrated under reduced pressure. The crude product was purified by flash silica gel chromatography to give 0.35 g (78%) of azide 26 as a pale yellow oil; IR (thin film) 2951, 2108, and 1315 cm−1; 1H-NMR (CDCl3, 400 MHz) δ 1.20 (t, 3H, J= 7.6 Hz), 1.90 (p, 2H, J= 6.8 Hz), 2.59 (q, 2H, J= 7.2 Hz), 2.67 (t, 2H, J= 7.2 Hz), 3.31 (t, 2H, J = 6.8 Hz), 5.85 (d, 1H, J= 2.8 Hz), and 5.89 (d, 1H, J= 3.2 Hz); 13C-NMR (CDCl3, 100 MHz) δ 12.4, 21.5, 25.3, 27.7, 50.9, 104.4, 106.1, 152.7, and 156.7.
1-[3-(5-Ethyl-furan-2-yl)propyl]-3a-methyl-1,3,3a,4,5,6-hexahydroindol-2-one (29)
To a solution containing 0.35 g (2.0 mmol) of the above azide 26 in xylene (5 mL) in a microwave reaction tube was added tributylphosphine (1.0 mmol). The mixture was stirred for 1 h at room temperature, the solvent was removed under reduced pressure and 5 mL of xylene was added followed by ketoacid 14. The reaction mixture was subjected to microwave irradiation at 180 °C for 10 min. Removal of the solvent left a crude residue which was chromatographed on a silica gel column to give hexahydroindolinone 29 (80%) as a colorless oil; IR (thin film) 2935, 1721, 1681, 1455, and 1404 cm−1; 1H-NMR (400 MHz, CDCl3) δ 1.18 (s, 3H), 1.21 (t, 3H, J= 7.6 Hz), 1.53 (m, 1H), 1.70–1.90 (m, 5H), 2.04–2.22 (m, 2H), 2.25 (s, 3H), 2.59 (m, 4H), 3.24 (ddd, 1H, J= 14.0, 8.4 and 6.0 Hz), 3.67 (ddd, 1H, J= 14.0, 8.4 and 7.2 Hz), 4.75 (t, 1H, J= 3.6 Hz), and 5.85 (d, 1H, J= 3.0 Hz); 13C-NMR (100 MHz, CDCl3) δ 12.4, 18.5, 21.5, 22.8, 25.5, 25.7, 26.3, 34.0, 36.3, 38.8, 46.5, 97.3, 104.4, 105.7, 145.8, 153.3, 156.4, and 173.9; HRMS Calcd. for C18H25NO2: 287.1885. Found: 287.1879.
2-Ethyl-9-methyl-9,9a-cyclohexyl-4,5,6,8,9,9a-hexahydro-3-oxa-6a-azacyclo-penta[e]azulen-7-one (30)
To a solution of 0.1 g (0.3 mmol) of hexahydroindolone 29 in 3.5 mL of CH2Cl2 was added trifluoroacetic acid (0.08 mL, 1.0 mmol). The mixture was stirred at 25 °C for 4 h and the solvent was removed under reduced pressure. The crude product was purified by flash silica gel chromatography to give 30 as a colorless oil in 96% yield; IR (thin film) 2936, 1774, 1689, and 1170 cm−1; 1H-NMR (400 MHz, CDCl3) δ 1.08 (s, 3H), 1.20 (t, 3H, J= 7.6 Hz), 1.41 (m, 1H), 1.57–1.75 (m, 6H), 1.86 (m, 1H), 2.00 (m, 2H), 2.23 (d, 1H, J= 16.0 Hz), 2.38 (d, 1H, J= 16.4 Hz), 2.55 (q, 2H, J=7.3 Hz), 2.69 (m, 2H), 2.95 (dt, 1H, J =14.0 and 6.8 Hz), 4.21 (dt, 1H, J= 14.6 and 6.8 Hz), and 5.88 (s, 1H); 13C-NMR (100 MHz, CDCl3) δ 12.2, 21.4, 21.5, 22.0, 23.9, 24.8, 25.8, 33.7, 35.3, 37.4, 40.9, 43.8, 67.4, 105.5, 122.5, 150.0, 155.0, and 176.8; HRMS Calcd. for C18H25NO2: 287.1885. Found: 287.1882.
1-(2-(Furan-3-yl)ethyl)-3a-methyl-3a,4,5,6-tetrahydro-1H-indol-2(3H)-one (31)
To a 0 °C solution of 5 g (26 mmol) of commercially available furan-3-carbaldehyde in THF (44 mL) was added 2 g (52 mmol) of lithium aluminum hydride in portions. The reaction mixture was stirred at 0 °C for 30 min. Following completion of the addition, the mixture was allowed to warm to room temperature and was quenched with a small amount of water and then MgSO4. The mixture was filtered and concentrated under reduced pressure. The resulting alcohol was dissolved in 87 mL of CH2Cl2 and cooled to 0 °C with stirring. After 5 min, mesyl chloride (3.0 mL, 39 mmol) and Et3N (5.4 mL, 39 mmol) were added and the cold bath was removed. The reaction mixture was stirred at room temperature for 1 h and quenched with a saturated ammonium chloride solution. The organic layer was separated and the aqueous was extracted with Et2O. The organic layers were combined, dried over MgSO4, filtered and concentrated under reduced pressure to give furan-3-ylmethyl methanesulfonate. To this compound was added 55 mL of DMF and 1 g (22 mmol) of sodium cyanide and the mixture was stirred vigorously overnight at room temperature. Water was added and the reaction mixture was extracted with Et2O. The organic layers were washed with a saturated NaCl solution, dried over MgSO4, filtered and concentrated under reduced pressure. The resulting nitrile was dissolved in 26 mL of methanol and 2.5 g (10.5 mmol) of cobalt chloride-hexahydrate was added with vigorous stirring. The mixture was cooled to 0 °C and 1.9 g (52 mmol) of NaBH4 was then added. The solution was warmed to room temperature, stirred for 3.5 h and 3N HCl was added and the mixture was stirred for an additional 1.5 h. The mixture was concentrated under reduced pressure and taken up in NH4OH. The basified solution was extracted with EtOAc and dried over sodium sulfate. The solution was decanted and concentrated under reduced pressure to give 0.17 g of 2-(furan-3-yl)ethanamine39 as a yellow oil which was immediately used in the next step; 1H-NMR (400 MHz, CDCl3) δ 1.60 (brs, 2H), 2.53 (t, 2H, J= 8.8 Hz), 2.86 (t, 2H, J= 8.8 Hz), 6.26 (s, 1H), 7.24 (d, 1H, J= 0.8 Hz) and 7.34 (s, 1H); 13C-NMR (100 MHz, CDCl3) δ 29.1, 42.4, 110.9, 122.5, 139.6 and 143.0.
To a solution containing 0.1 g (0.6 mmol) of keto acid 14 in 2 mL of xylene in a microwave reaction tube was added 0.08 g (0.73 mmol) of the above 2-(furan-3-yl)ethanamine and the vessel was sealed. The mixture was subjected to microwave irradiation at 180 °C for 20 min. The solvent was then removed under reduced pressure and the crude residue was purified by flash silica gel chromatography to give 0.06 g (42%) of 31 as a colorless oil; IR (neat) 1721, 1685, 1407, 1019, 873 and 786 cm−1;1H-NMR (400 MHz, CDCl3) δ 1.08 (s, 3H), 1.46–1.56 (m, 1H), 1.72–1.77 (m, 2H), 1.80 (q, 1H, J= 3.2 Hz), 2.09 (ddd, 1H, J= 17.6, 9.2 and 3.6 Hz), 2.21 (s, 2H), 2.25 (dd, 1H, J= 8.8 and 3.6 Hz), 2.66 (t, 2H, J= 7.6 Hz), 3.33 (dt, 1H, J= 13.6 and 6.8 Hz), 3.87 (dt, 1H, J= 14.0 and 8.4 Hz), 4.78 (t, 1H, J = 4.0 Hz), 6.31 (d, 1H, J= 0.4 Hz), 7.24 (dd, 1H, J= 1.2 and 0.4 Hz) and 7.33 (t, 1H, J= 1.6 Hz); 13C-NMR (100 MHz, CDCl3) δ 18.5, 22.2, 22.8, 26.1, 34.0, 36.3, 39.2, 46.4, 97.4, 111.1, 121.5, 139.7, 143.1, 145.6 and 173.8; HRMS Calcd for C15H19NO2[M+H+]: 246.1494. Found: 246.1481.
8-Methyl-8,8a-cyclohexyl-4,7,8,8a-tetrahydro-5H-oxa-5a-aza-as-indacen-6-one (32)
To a solution of 0.03 g (0.12 mmol) of tetrahydroindolinone 31 in 2 mL of CH2Cl2 was added trifluoroacetic acid (0.04 mL, 0.49 mmol) under argon. The reaction mixture was stirred at room temperature for 4 h and was then concentrated under reduced pressure. The resulting residue was purified by flash silica gel chromatography to give 0.04 g (98%) of 32 as a white crystalline solid, mp 120–122 °C; IR (neat) 1688, 1448, 1410, 1295, 1170 and 888 cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.61 (s, 3H), 1.38 (m, 1H), 1.52 (dd, 1H, J= 13.4 and 4.6 Hz), 1.59–1.74 (m, 5H), 1.83 (d, 1H, J= 16 Hz), 2.13 (d, 1H, J= 12.8 Hz), 2.43 (ddd, 1H, J= 15.6, 4.8 and 1.2 Hz), 2.54 (ddd, 1H, J= 15.6, 11.4 and 6.0 Hz), 2.73 (d, 1H, J= 16.0 Hz), 2.86 (ddd, 1H, J= 12.4, 4.8 and 1.2 Hz), 4.24 (ddd, 1H, J= 12.8, 6.0 and 1.2 Hz), 6.19 (d, 1H, J=1.6 Hz) and 7.26 (d, 1H, J= 2.0 Hz); 13C-NMR (100 MHz, CDCl3) δ 22.0, 22.1, 22.8, 25.9, 33.7, 34.7, 35.5, 41.0, 42.2, 64.1, 110.1, 115.3, 141.6, 152.4 and 172.4; HRMS Calcd for C15H19NO2[M+H+]: 246.1494. Found: 246.1488.
3a-Methyl-1-(2-thiophen-3-yl-ethyl)-1,3,3a,4,5,6-hexahydroindol-2-one (33)
To a solution of 0.17 g (1.0 mmol) of keto acid 14 in 3 mL of xylene in a micro-wave reaction tube was added 0.15 g (1.2 mmol) of 2-(thiophen-3-yl)ethanamine39 and the mixture was subjected to microwave irradiation at 175 °C for 20 min. Removal of the crude solvent left a crude residue which was purified by flash silica gel chromatography to give 0.14 g (55%) of 33 as a yellow oil; IR (neat) 3375, 1719, 1671, 1448, 1401, 1311, 1159, and 779 cm−1;1H-NMR (600 MHz, CDCl3) δ 1.50 (s, 3H), 1.47–1.53 (m, 1H), 1.72–1.79 (m, 3H), 2.08 (ddd, 1H, J= 12.0, 6.0 and 2.0 Hz), 2.20 (d, 2H, J= 2.4 Hz), 2.23 (q, 1H, J= 2.8 Hz), 2.89 (t, 2H, J= 5.2 Hz), 3.39 (dt, 1H, J= 9.2, and 4.4 Hz), 3.93 (dt, 1H, J= 9.2 and 5.2 Hz), 4.78 (t, 1H, J= 2.8 Hz), 6.96 (d, 1H, J= 3.2 Hz), 6.99 (d, 1H, J= 1.2 Hz) and 7.23 (dd, 1H, J= 3.2 and 2.0 Hz) ; 13C-NMR (150 MHz, CDCl3) δ 18.5, 22.8, 26.0, 27.3, 34.0, 36.3, 39.5, 46.3, 97.4, 121.5, 125.6, 128.3, 138.8, 145.5 and 173.8 ; HRMS Calcd for C15H19NOS [M+H+]: 262.1287. Found: 262.1254.
8-Methyl-8,8a-cyclohexyl-4,7,8,8a-tetrahydro-5H-mercapto-5a-aza-as-indacene-6-one (34)
To a solution of 0.03 g (0.11 mmol) of tetrahydroindolinone 33 in 1.1 mL of CH2Cl2 was added trifluoroacetic acid (0.02 mL, 0.3 mmol) under argon. The reaction mixture was stirred at 25 °C for 4 h, concentrated under reduced pressure and the resulting residue was purified by flash silica gel chromatography to give 0.02 g (73%) of 34 as a crystalline solid, mp 138–140 °C; IR (neat) 3462, 2919, 1685, 1445, 1414 and 861 cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.68 (s, 3H), 1.45–1.55 (m, 1H), 1.57–1.66 (m, 1H), 1.69–1.79 (m, 5H), 1.91 (d, 1H, J = 16.0 Hz), 2.18 (dq, 1H, J=12.8 and 2.8 Hz), 2.63–2.77 (m, 2H), 2.84 (d, 1H, J = 16.0 Hz), 2.94 (tdd, 1H, J=11.6, 4.8 and 1.6 Hz), 4.34 (ddd, 1H, J= 13.2, 6.0 and 1.6 Hz), 6.83 (d, 1H, J= 4.8 Hz) and 7.15 (d, 1H, J= 4.8 Hz); 13C-NMR (100 MHz, CDCl3) δ 21.6, 22.2, 26.1, 26.2, 32.8, 34.4, 37.0, 41.3, 41.9, 65.7, 123.0, 127.0, 134.1, 136.3 and 171.9; Anal. Calcd. for C15H19NOS: C, 68.93; H, 7.33; N, 5.36. Found: C, 68.79; H, 7.34; N, 5.39.
3a-Methyl-1-(2-thiophen-2-ylethyl)-1,3,3a,4,5,6-hexahydroindol-2-one (35)
To a solution containing 0.11 g (0.68 mmol) of keto acid 14 in 1 mL of xylene in a microwave reaction tube was added 0.1 mL (0.86 mmol) of 2-thiophen-2-yl-ethanamine39 and the vessel was subjected to microwave irradiation at 180 °C for 20 min. The crude residue obtained upon removal of the solvent was purified by flash silica gel chromatography to give 0.14 g (79%) of 35 as a pale yellow oil; IR (neat) 1676, 1452, 1404, 1317, 1171 and 695 cm−1; 1H-NMR (600 MHz, CDCl3) δ 1.10(s, 3H), 1.51 (m, 1H), 1.75(m, 2H), 1.79(t, 1H, J= 3.2 Hz), 2.08 (qd, 1H, J = 9.0 and 3.6 Hz), 2.22 (m, 3H), 3.04 (m, 2H), 3.44 (m, 1H), 3.92 (m, 1H), 4.78 (t, 1H, J= 4.0 Hz), 6.84 (m, 1H), 6.90 (dd, 1H, J= 4.8 and 3.6 Hz) and 7.11 (dd, 1H, J=5.0 and 1.4 Hz); 13C-NMR (150 MHz, CDCl3) δ 18.5, 22.8, 26.1, 27.1, 34.0, 36.3, 40.6, 46.4, 97.3, 123.9, 125.4, 127.0, 140.8, 145.5 and 173.8; HRMS Calcd for C15H19NOS [M+H+]: 262.1287. Found: 262.1282.
8-Methyl-8,8a-cyclohexyl-4,7,8,8a-tetrahydro-5H-mercapto-5a-aza-as-indacene-6-one (36)
A mixture containing tetrahydroindolinone 35 in 5 mL of polyphosphoric acid was stirred at 90 °C for 12 h. The reaction mixture was poured into ice water and extracted with CHCl3. The organic layer was washed with H2O, dried over MgSO4, filtered and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography to give 0.01 g (33%) of 36 as a yellow solid, mp 102–104 °C; IR (neat) 1683, 1450, 1416, 1325, 1239, 1032 and 727 cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.66 (s, 3H), 1.65 (m, 7H), 1.91 (d, 1H, J= 16 Hz), 2.16 (m, 1H), 2.80 (s, 1H), 2.86 (m, 2H), 3.02 (m, 1H), 4.39 (ddd, 1H, J =13.2, 4.8 and 2.8 Hz), 7.06 (d, 1H, J= 5.6 Hz) and 7.15 (d, 1H, J=4.8 Hz); 13C-NMR (100 MHz, CDCl3) δ 21.8, 25.2, 26.5, 33.3, 34.4, 36.8, 40.6, 42.2, 65.2, 78.9, 122.9, 125.1, 133.6, 137.3 and 171.9; HRMSCalcd for C15H19NOS [M+H+]: 262.1287. Found: 262.1281.
8-Methyl-8,8a-cyclohexyl-3,4,5,7,8,8a-hexahydro-3,5a-diaza-as-indacen-6-one (38)
To a solution of 0.02 g (0.13 mmol) of keto acid 14 in 2 mL of xylene in a microwave reaction tube was added 0.02 g (0.14 mmol) of 2-(1H-pyrrol-2-yl)ethanamine40 and the mixture was subjected to microwave irradiation at 70 °C for 30 min. The solution was concentrated under reduced pressure and the resulting residue was purified by flash silica gel chromatography to give 0.02 g (70%) of 38 as a clear oil; IR (neat) 3315, 2925, 1762, 1653, 1451, 1232, 1099 and 917 cm−1; 1H-NMR (400 MHz, CDCl3) δ 0.67 (s, 3H), 1.46–1.78 (m, 7H), 1.88 (d, 1H, J= 16.0 Hz), 2.10–2.14 (m, 1H), 2.61 (dd, 1H, J= 14.8 and 4.4 Hz), 2.73 (ddd, 1H, J= 14.8, 11.6 and 6.0 Hz), 2.80 (d, 1H, J= 16.0 Hz), 3.01 (tdd, 1H, J= 12.4, 4.8 and 1.6 Hz), 4.34 (ddd, 1H, J= 13.2, 6.0 and 1.2 Hz), 6.14 (t, 1H, J= 2.8 Hz), 6.67 (t, 1H, J= 2.8 Hz) and 8.21 (s, 1H); 13C-NMR (100 MHz, CDCl3) δ 22.0, 22.1, 22.9, 26.7, 33.5, 34.1, 37.2, 40.7, 42.2, 64.4, 105.8, 116.5, 119.7, 123.9 and 172.6; Anal. Calcd. for C15H20N2O: C, 73.74; H, 8.25; N, 11.47. Found: C, 73.56; H, 8.28; N, 11.25.
1 -Methyl-1,11b-cyclohexyl-1,2,5,6,11,11b-hexahydroindolizino[8,7-b]indol-3-one (40)
To a solution of 0.17 g (1.0 mmol) of keto acid 14 in 1 mL of xylene in a microwave reaction tube was added 0.19 g (1.2 mmol) of 2-(1H-indol-3-yl)ethan amine (39) and trifluoroacetic acid (0.08 mL, 1.0 mmol) and the mixture was subjected to microwave irradiation at 180 °C for 20 min. The solution was concentrated under reduced pressure and the residue was purified by flash silica gel chromatography to give 0.25 g (85%) of 40 as a crystalline solid: mp 268–269 °C; IR (neat) 3271, 1662, 1421, 1290, 1021 and 746 cm−1; 1H-NMR (600 MHz, CDCl3) δ 0.89 (s, 3H), 1.97 (m, 7H), 2.21 (dd, 1H, J = 13.2 and 3.6 Hz), 2.45 (d, 1H, J = 13.2 Hz), 2.88 (m, 1H), 3.08 (dd, 1H, J = 15.6 and 4.2 Hz), 3.12 (d, 1H, J = 16.2 Hz), 3.25 (dd, 1H, J = 12 and 4.2 Hz), 4.50 (dd, 1H, J = 12.6 and 6.0 Hz), 7.28 (t, 1H, J = 7.8Hz), 7.37 (t, 1H, J = 7.8Hz), 7.71 (m, 2H) and 10.93 (s, 1H); 13C-NMR (150 MHz, CDCl3) δ 21.0, 21.1, 21.2, 25.9, 32.3, 33.9, 35.5, 41.5, 63.1, 96.8, 106.7, 111.5, 117.8, 118.6, 121.0, 125.9, 135.5, 136.3 and 170.4; Anal. Calcd. for C19H22N2O: C, 77.52; H, 7.53; N, 9.52. Found: C, 77.13; H, 7.52; N, 9.47.
1-Methyl-1,10c-cyclohexyl-1,2,4,5,6,10c-hexahydro-3a,6-diazacyclopenta[c]-fluoren-3-one (42)
To a solution of 0.05 g (0.3 mmol) of keto acid 14 in 2 mL of xylene in a microwave reaction tube was added 0.058 g (0.36 mmol) of 2-(1H-indol-2-yl)ethanamine (41)41 and the vessel was subjected to microwave irradiation at 180 °C for 20 min. The solution was concentrated under reduced pressure and the residue was purified by flash silica gel chromatography to give 0.05 g (90%) of 42 as a yellow oil; IR (neat) 3262, 2921,1662,1450, 1321 and 746 cm−1; 1H-NMR (300 MHz, CDCl3) δ 0.79 (s, 3H), 1.55–1.97 (m, 4H), 2.02 (d, 1H, J = 16.5 Hz), 2.14–2.33 (m, 4H), 2.72 (dd, 1H, J = 16.0 and 4.8 Hz), 2.86 (d, 1H, J = 16.5 Hz), 2.91–3.00 (m, 1H), 3.08 (td, 1H, J = 12.3 and 4.8 Hz), 4.46 (dd, 1H, J = 12.9 and 5.7 Hz), 7.07–7.17 (m, 2H), 7.32 (d, 1H, J = 7.8 Hz), 7.78 (d, 1H, J = 7.8 Hz) and 8.25 (s, 1H); 13C-NMR (75 MHz, CDCl3) δ 20.5, 21.0, 23.8, 27.2, 32.8, 33.8, 36.8, 40.0, 43.6, 66.7, 111.2, 114.1, 119.7, 121.0,121.5,125.6, 132.3, 136.0 and 172.5; HRMS Calcd for C19H22N2O [M+H+]: 295.1810. Found: 295.1808.
In addition, varying amounts of the oxidized 1-methyl-1, 10c-cyclohexyl-1,2,6,10c-tetrahydro-3a,6-diazacyclopenta[c]-fluoren-3-one derived from 42 was also isolated as a pale yellow oil; IR (neat) 3278, 2925, 1685, 1629, 1450, 1414, 1368 and 753 cm−1; 1H-NMR (600 MHz, CDCl3) δ 1.21 (s, 3H), 1.50–1.62 (m, 4H), 1.93–1.99 (m, 2H), 2.06 (d, 1H, J = 16.8 Hz), 2.33–2.39 (m, 2H), 2.92 (d, 1H, J = 16.8 Hz), 5.86 (d, 1H, J = 7.2 Hz), 6.99 (d, 1H, J = 7.2 Hz), 7.12 (m, 2H), 7.31–7.32 (m, 1H), 7.80–7.81 (m, 1H) and 8.16 (s, 1H); 13C-NMR (100 MHz, CDCl3) δ 22.0, 22.3, 26.9, 34.2, 40.2, 42.1, 42.8, 70.1, 100.7, 102.0, 111.5, 120.6, 120.8, 121.6, 122.0, 125.7, 131.7, 136.5 and 173.0; HRMS Calcd. for C19H20N2O [M+H+]: 293.1654. Found: 293.1649.
2-[(2-Ethylsulfanylacetyl)-(2-furan-2-yl-ethyl)amino]cyclohex-1-ene-carboxylic Acid Ethyl Ester (44)
To a solution of 7.7 g (68 mmol) of 2-furan-2-yl-ethan-1-ol33 in 140 mL of CH2Cl2 at 0 °C was added 8.3 g (72 mmol) of methanesulfonylchloride followed by the slow addition of 10.4 g (100 mmol) of triethylamine. The solution was warmed to room temperature over 30 min, quenched with water and extracted with CH2Cl2. The organic extracts were dried over MgSO4, filtered and concentrated under reduced pressure. The crude product was taken up in 140 mL of DMF and 8.9 g (130 mmol) of sodium azide was added. The reaction was stirred at 50 °C for 15 h. After cooling to 25 °C, 350 mL of water was added and the solution was extracted with ether. The ether extracts were washed with brine, dried over MgSO4, concentrated under reduced pressure and subjected to flash silica gel chromatography to give 8.3 g (88%) of 2-(2-azidoethyl)furan as a pale yellow oil which was used in the next step without further purification;1H-NMR (400 MHz, CDCl3) δ 2.90 (t, 2H, J = 7.6 Hz), 3.55 (t, 2H, J = 7.6 Hz), 6.15 (m, 1H), 6.30 (m, 1H), and 7.30 (m, 1H); 13C-NMR (150 MHz, CDCl3) δ 28.2, 49.9, 107.0, 110.6, 141.8, and 152.0.
To a solution of 0.3 g of the above azide (2.5 mmol) in 12 mL of toluene was added tributylphosphine (2.5 mmol). The reaction mixture was stirred for 1 h at room temperature and 2-oxo-cyclohexanecarboxylic acid ethyl ester (2.5 mmol) was added and the vessel was sealed with a septum. The reaction mixture was subjected to microwave irradiation at 150 °C for 30 min. After cooling to 0 °C, powdered 4Å molecular sieves (2.5 g) was added followed by a solution of (ethylsulfanyl)acetyl chloride (prepared from 0.37 g, 3.0 mmol of (ethylsulfanyl)-acetic acid). After warming to room temperature overnight, the solution was filtered and concentrated under reduced pressure. The residue was subjected to flash silica gel chromatography to give 0.4 g (44%) of 44 as a colorless oil; 1H-NMR (400 MHz, CDCl3) δ 1.26 (t, 6H, J = 7.2 Hz), 1.66 (m, 4H), 2.15 (m, 1H), 2.21 (m, 1H), 2.38 (m, 2H), 2.68 (m, 2H), 2.88 (m, 1H), 2.99 (m, 1H), 3.19 (m, 1H), 3.32 (m, 1H), 3.57 (m, 1H), 3.75 (m, 1H), 4.14 (qd, 2H, J = 7.2 and 2.4 Hz), 6.04 (d, 1H, J = 3.2 Hz), 6.27 (dd, 1H, J = 2.8 and 2.4 Hz), 7.30 (d, 1H, J = 2.0 Hz); 13C-NMR (100 MHz, CDCl3) δ 14.3, 14.5, 21.6, 22.4, 26.6, 26.7, 26.9, 30.4, 33.3, 47.0, 61.3, 106.4, 110.5, 129.5, 141.3, 145.1, 153.3, 167.2, and 169.1; HRMS Calcd. for C19H27NO4S [M+H+]: 366.1739. Found: 366.1741.
2-[(2-Ethanesulfinylacetyl)-(2-furan-2-ylethyl)amino]cyclohex-1-ene-carboxylic Acid Ethyl Ester (46)
To a solution of 0.4 g (1.1 mmol) of the above sulfide 44 in 5 mL of 20% aqueous methanol was added 0.5 g (2.2 mmol) of sodium periodate. After stirring for 15 h at room temperature, water was added and the solution was extracted with chloroform. The chloroform layer was dried over MgSO4, filtered and concentrated under reduced pressure. The crude product was purified using flash silica gel chromatography to give 0.39 g (95%) of sulfoxide 46 as a colorless oil; 1H-NMR (400 MHz, CDCl3) δ 1.28 (dt, 3H, J = 7.6 and 7.2 Hz), 1.39 (t, 3H, J = 7.6 Hz), 1.67 (m, 4H), 2.14 (m, 2H), 2.42 (m, 2H), 2.83 (m, 2H), 2.96 (m, 1H), 3.15 (M, 1H), 3.59–3.90 (m, 4H), 4.16 (dq, 2H, J = 11.6 and 7.2 Hz), 6.04 (dd, 1H, J = 4.0 and 3.6 Hz), 6.28 (dd, 1H, J = 2.4 Hz), and 7.30 (dd, 1H, J = 0.8 and 0.8 Hz); 13C-NMR (100 MHz, CDCl3) δ 6.59, 6.87, 14.3, 21.5, 22.3, 26.6, 26.7, 26.8, 26.9, 30.5, 30.7, 46.5, 46.8, 47.1, 54.9, 56.5, 61.4, 61.5, 106.6, 110.6, 130.7, 141.5, 144.1, 152.7, 164.5, and 166.8; HRMS Calcd. for C19H27NO5S [M+H+]: 382.1688. Found: 382.1685.
1,2-Furanyl Fused Ethyl 6-Oxodecahydro-1H-pyrido[1,2-i]indole-7a-carboxylate (48)
To a solution of 0.24 g (0.6 mmol) of sulfoxide 46 in 6 mL of CH2Cl2 at 0 °C was added 0.14 g (0.69 mmol) of trifluoroacetic anhydride. After stirring for 10 min at 0 °C, 0.15 mL of trifluoroacetic acid was added and the mixture was allowed to warm to room temperature over 2 h. The reaction was concentrated under reduced pressure and the residue was subjected to flash silica gel chromatography to give 0.17 g (76%) of 48 as a colorless oil which consisted of a single diastereomer; 1H-NMR (400 MHz, CDCl3) δ 0.95 (t, 3H, J = 7.2 Hz), 1.30 (t, 3H, J = 7.6 Hz), 1.44 (m, 1H), 1.53 (m, 1H), 1.66 (m, 1H), 1.74 (m, 1H), 1.96 (d, 1H, J = 14.0 Hz), 2.17 (d, 1H, J = 15.6 Hz), 2.23 (d, 1H, J = 12.8 Hz), 2.36 (m, 1H), 2.70 (m, 4H), 3.06 (m, 1H), 3.65 (s, 1H), 3.81 (q, 2H, J = 6.8 Hz), 4.50 (ddd, 1H, J = 12.8, 6.0, and 0.8 Hz), 6.38 (d, 1H, J = 0.8 Hz), and 7.24 (d, 1H, J = 0.8 Hz); 13C-NMR (100 MHz, CDCl3) δ 13.8, 15.4, 21.2, 21.5, 23.1, 26.1, 28.9, 34.7, 37.6, 51.8, 57.8, 60.8,61.1, 108.4, 119.2, 141.4, 148.0,170.1 and 171.3; HRMS Calcd. for C19H25NO4S [M+H+]: 364.1582. Found: 364.1580.
2-[[3-(5-Ethyl-furan-2-yl)propyl]-(2-ethylsulfanylacetyl)amino]cyclohex-1-enecarboxylic Acid Ethyl Ester (45)
To a solution of 0.37 g of 2-(3-azido-propyl)-5-ethyl-furan (26) (2.4 mmol) in 12 mL of toluene was added tributylphosphine (2.4 mmol). The reaction mixture was stirred for 1 h at room temperature and then 2-oxo-cyclohexane-carboxylic acid ethyl ester (0.4 g, 2.5 mmol) was added and the vessel was sealed with a septum. The reaction mixture was subjected to microwave irradiation at 150 °C for 30 min. After cooling to 0 °C, powdered 4Å molecular sieves (2.5 g) was added followed by a solution of (ethylsulfanyl)acetyl chloride (prepared from 0.37 g, 3.0 mmol of (ethylsulfanyl)-acetic acid). After warming to room temperature overnight, the solution was filtered and concentrated under reduced pressure. The residue was subjected to flash silica gel chromatography to give 0.64 g (65%) of the title compound 45 as a colorless oil; 1H-NMR (400 MHz, CDCl3) δ 1.19 (t, 3H, J = 7.4 Hz), 1.25 (t, 3H, J = 6.8 Hz), 1.26 (t, 3H, J = 7.2 Hz), 1.63–1.77 (m, 4H), 1.86 (m, 2H), 2.32–2.42 (m, 4H), 2.57 (t, 4H, J = 7.2 Hz), 2.60–2.74 (m, 2H), 3.21 (d, 1H, J = 14.4 Hz), 3.34 (d, 1H, J = 14.4 Hz), 3.44 (ddd, 2H, J = 16.4, 7.6 and 6.4 Hz), 4.14 (qd, 2H, J = 7.6 and 1.6 Hz), 5.83 (d, 1H, J = 3.2 Hz) and 5.88 (d, 1H, J = 3.2 Hz); 13C-NMR (100 MHz, CDCl3) δ 12.4, 14.3, 14.5, 21.5, 21.7, 22.5, 25.9, 26.7, 26.8, 30.6, 33.3, 47.4, 61.2, 104.4, 105.5, 129.5, 144.7, 153.4, 156.3, 167.3 and 169.0; HRMS Calcd. for C22H33NO4S: 407.2130. Found: 407.2127.
2-{(2-Ethanesulfinylacetyl)-[3-(5-ethyl-furan-2-yl)propyl]amino}cyclohex-1-enecarboxylic Acid Ethyl Ester (47)
To a solution of 0.6 g (1.5 mmol) of the above sulfide 45 in 15 mL of a 20% aqueous methanol solution was added 0.7 g (3.0 mmol) of sodium periodate. After stirring for 15 h at room temperature, water was added and the solution was extracted with chloroform. The chloroform extracts were dried over MgSO4, filtered and concentrated under reduced pressure. The crude product was purified using flash silica gel chromatography to give 0.4 g (62%) of sulfoxide 47 as a colorless oil; 1H-NMR (400 MHz, CDCl3) δ 1.18 (t, 3H, J = 7.8 Hz), 1.24 (m, 3H), 1.37 (t, 3H, J = 7.8 Hz), 1.67 (m, 3H), 2.81 (m, 3H), 2.12–2.24 (m, 1H), 2.33 (m, 2H), 2.48 (m, 1H), 2.55 (m, 4H), 2.84 (m, 1H), 3.12 (m, 1H), 3.30–3.54 (m, 2H), 3.67 (dd, 1H, J = 6.0 and 3.9 Hz), 3.85 (dd, 1H, J = 14.4 and 3.9 Hz), 4.14 (dq, 2H, J = 18.6 and 7.2 Hz), 5.82 (d, 1H, J = 3.0 Hz), and 5.85 (d, 1H, J = 3.0 Hz); 13C-NMR (100 MHz, CDCl3) δ 6.5, 6.8, 12.3, 14.3, 21.5, 22.3, 25.8, 26.5, 26.6, 30.6, 30.9, 46.5, 46.8, 47.1, 61.3, 61.4, 104.4, 105.6, 130.8, 130.9, 143.3, 143.6, 152.9, 153.0, 156.3, 163.9, 164.4 and 166.9; HRMS Calcd. for C22H33NO5S: 423.2079. Found: 423.2083.
1,2-Furanyl Fused Ethyl 7-oxo-8-(phenylthio)dodecahydroazepino[1,2-i]-indole-8a-carboxylate (49)
To a solution of 0.24 g (0.6 mmol) of sulfoxide 47 in 6 mL of CH2Cl2 at 0 °C was added 0.13 g (0.6 mmol) of trifluoroacetic anhydride. After stirring for 10 min at 0 °C, 0.15 mL of trifluoroacetic acid was added and the mixture was allowed to warm to room temperature over 2 h. The solution was concentrated under reduced pressure and the residue was subjected to flash silica gel chromatography to give 0.09 g (40%) of the title compound as a clear oil; 1H-NMR (600 MHz, CDCl3) δ 0.99 (t, 3H, J = 6.6 Hz), 1.17 (t, 3H, J = 7.8 Hz), 1.26 (t, 3H, J = 7.8 Hz), 1.43 (m, 1H), 1.62 (m, 3H), 1.92 (m, 3H), 2.11 (m, 1H), 2.30 (m, 2H), 2.50 (q, 2H, J = 7.8 Hz), 2.71 (m, 3H), 2.85 (m, 1H), 2.94 (m, 1H), 3.52 (s, 1H), 3.89 (m, 2H), 4.22 (dt, 1H, J = 13.8 and 4.8 Hz) and 5.97 (s, 1H); 13C-NMR (100 MHz, CDCl3) δ 12.3, 13.7, 15.2, 20.8, 20.9, 21.3, 24.5, 26.4, 29.1, 37.0, 39.7, 51.7, 57.6,61.1,64.0, 105.0, 105.1, 121.9, 148.1, 155.3, 171.4 and 172.8; HRMS Calcd. for C22H31NO4S: 405.1974. Found: 405.1977.
3-Ethylsulfanyl-1-(3-furan-2-ylpropyl)-2-oxo-1,2,3,4,5,6-hexahydroindole-3a-carboxylic Acid Ethyl Ester (51)
To a solution of 2.0 g of 3-(furan-2-yl)-propylamine33 (16.0 mmol) in 80 mL toluene was added 2-oxo-cyclohexane-carboxylic acid ethyl ester (2.7 g, 16 mmol) and the solution was heated at reflux for 15 h using a condenser and Dean-Stark trap. After cooling to rt, powdered 4Å molecular sieves (16 g) was added and the mixture was chilled to 0 °C. A solution of (ethylsulfanyl)acetyl chloride (prepared from 1.2 g (17.6 mmol) of ethylsufanyl acetic acid) in 35 mL of toluene was slowly added. The solution was allowed to slowly warm to rt and was stirred for an additional 15 h at 25 °C. The solution was filtered through a pad of Celite and concentrated under reduced pressure. The residue was subjected to flash silica gel chromatography to provide 2.8 g (46%) of 2-[(2-ethylsulfanylacetyl)-(3-furan-2-yl-propyl)amino-cyclohex-1-ene-carboxylicacid ethyl ester as a thick oil; 1H-NMR (CDCl3, 400 MHz) δ 1.20 (t, 3H, J = 5.6 Hz), 1.22 (t, 3H, J = 7.6 Hz), 1.64 (m, 4H), 1.85 (m, 2H), 2.30–2.50 (m 4H), 2.59 (t, 2H, J = 7.6 Hz), 2.65 (m, 2H), 3.17 (m, 1H), 3.30 (m, 1H), 3.41 (m, 2H), 4.10 (qd, 2H, J = 7.2 and 1.2 Hz), 5.94 (dd, 1H, J = 3.2 and 0.8 Hz), 6.22 (dd, 1H, J = 3.2 and 2.0 Hz), 7.24 (d, 1H, J=0.8 Hz); 13C-NMR (CDCl3, 100 MHz) δ 13.9, 14.2, 21.4, 22.1, 25.5, 26.2, 26.3, 26.4, 30.3, 33.0, 46.9, 60.8, 105.0, 110.0, 129.3, 140.7, 144.3, 155.0, 167.0, and 168.7; HRMS Calcd. for [C20H29NO4S]+: 379.1817. Found: 379.1829.
To a solution of 2.8 g (7.4 mmol) of the above sulfide in 35 mL of 20% aqueous methanol was added 2.4 g (11.0 mmol) of sodium periodate. After stirring at rt for 15 h, water was added and the solution was extracted with chloroform. The extracts were dried with MgSO4, filtered and concentrated under reduced pressure. The residue was subjected to flash silica gel chromatography to give 2.3 g (78%) of 2-[(2-ethanesulfinylacetyl)-(3-furan-2-yl-propyl)amino]-cyclohex-1-enecarboxylic acid ethyl ester (50) as a colorless oil; 1H-NMR (CDCl3, 400 MHz) δ 1.19 (m, 3H), 1.32 (t, 3H, J = 7.6 Hz), 1.62–1.81 (m, 6H), 2.19 (m, 1H), 2.29 (m, 2H), 2.45 (m, 1H), 2.56 (t, 2H, J = 7.6 Hz), 2.79 (m, 1H), 3.06 (m, 1H), 3.26–3.52 (m, 2H), 3.64 (m, 1H), 3.82 (m, 1H), 4.10 (dq, 2H, J = 13.2 and 7.6 Hz), 5.94 (d, 1H, J = 3.2 Hz), 6.20 (dd, 1H, J = 2.8 and 0.8 Hz), and 7.23 (d, 1H, J = 1.2 Hz); 13C-NMR (CDCl3, 100 MHz) δ 6.4, 6.7, 14.1, 21.3, 22.1, 25.5, 26.3, 26.4, 26.5, 30.5, 30.8, 46.4, 46.6, 46.8, 54.7, 56.5, 61.1, 61.3, 105.1, 110.1, 130.7, 130.8, 140.9, 143.2, 143.3, 154.9, 163.9, 164.3, 166.6, and 166.7; HRMS Calcd. for [C20H29NO5S]+: 395.1766. Found: 395.1767.
To a solution of 0.28 g (0.7 mmol) of sulfoxide 50 dissolved in 40 mL of benzene was added 0.7 g of 10-camphorsulfonic acid (2.8 mmol). The solution was heated at reflux for 30 min and then cooled to room temperature. The benzene solution was washed with a saturated sodium bicarbonate solution, dried with MgSO4, and concentrated under reduced pressure. The crude product was subjected to flash silica gel chromatography to give 0.18 g (70%) of 51 as a colorless oil; IR (thin film) 1725,1680,1404 and 1180 cm−1; 1H-NMR (CDCl3, 400 MHz) δ 1.20 (m, 3H), 1.25 (t, 3H, J = 7.2 Hz), 1.40 (m, 1H), 1.82–1.92 (m, 4H), 2.04–2.33 (m, 2H), 2.72 (m, 5H), 3.22 (m, 1H), 3.47 (m, 1H), 3.82 (m, 1H), 4.13 (m, 2H), 4.94 (t, 1H, J = 3.6 Hz), 6.02 (d, 1H, J = 3.2 Hz), 6.25 (dd, 1H, J = 3.2 and 1.6 Hz), and 7.28 (d, 1H, J = 0.8 Hz); 13C-NMR (CDCl3, 100 MHz) δ 14.2, 14.7, 19.6, 22.7, 25.0, 25.7, 27.1, 30.5, 39.6, 54.3, 55.4, 61.6, 100.7, 105.4, 110.3, 137.5, 141.1, 155.2, 170.3 and 171.1; HRMS Calcd. for C20H27NO4S [M+H+]: 378.1739. Found: 378.1729.
4-Bromo-5-(3-hydroxypropyl)furan-2-carboxylic Acid Methyl Ester
To a solution of 2.8 g (10 mmol) of 2,3-dibromo-5-carbomethoxvfuran42 in 50 mL of DMF was added 0.7 g (12 mmol) of allyl alcohol, 0.08 g (0.2 mmol) of palladium (II) acetate, 2.3 g (10 mmol) of benzyltriethylammonium chloride, and 2.1 g (25 mmol) of sodium bicarbonate. The reaction vessel was purged with Argon, sealed and heated to 80 °C for 2 h. After cooling to 25 °C, the solution was filtered through a pad of Celite and water was added to the filtrate. The solution was extracted with ether and the combined ether extracts were washed with brine, dried over MgSO4, filtered and concentrated under reduced pressure. The crude product was subjected to flash silica gel chromatography to give 1.9 g (73%) of methyl 4-bromo-5-(3-oxopropyl)furan-2-carboxylate as a colorless oil: 1H-NMR (CDCl3, 400 MHz) δ 2.90 (t, 2H, J = 6.8 Hz), 3.04 (t, 2H, J = 7.6 Hz), 3.87 (s, 3H), 7.11 (s, 1H), and 9.83 (s, 1H); 13C-NMR (CDCl3, 100 MHz) δ 19.4, 41.0, 52.3, 98.7, 121.4, 143.2, 155.6, 158.4, and 199.7. The aldehyde was used immediately in the next step.
A 0.6 g (2.3 mmol) sample of the above aldehyde was dissolved in methanol (12 mL) and the solution was cooled to 0 °C. To this solution was added 0.1 g (2.5 mmol) of sodium borohydride in several portions. After stirring for 30 min, the reaction mixture was quenched with water and extracted with ethyl acetate. The extracts were dried over MgSO4, filtered and concentrated under reduced pressure. The crude product was subjected to flash silica gel chromatography to give 0.46 g (77%) of the title alcohol as a clear oil; IR (thin film) 3418, 2951, 1734, 1533 and 1199 cm−1; 1H-NMR (CDCl3, 300 MHz) δ 1.82 (bs, 1H), 1.94 (p, 2H, J = 6.3 Hz), 2.84 (t, 2H, J = 7.2 Hz), 3.67 (t, 2H, J = 6.3 Hz), 3.87 (s, 3H), and 7.11 (s, 1H); 13C-NMR (CDCl3, 75 MHz) δ 23.1, 30.4, 52.3, 61.7, 98.4, 121.4, 142.9, 157.6, and 158.6; HRMS Calcd. for C9H11BrO4: 261.9841. Found: 261.9842.
5-(3-Azidopropyl)-4-bromo-furan-2-carboxylic Acid Methyl Ester (53)
To a solution of 0.46 g (1.7 mmol) of the above alcohol in 8.7 mL of CH2Cl2 at 0 °C was added 0.2 g (1.9 mmol) of methanesulfonyl chloride followed by 0.35 g (3.5 mmol) of triethylamine. After stirring for 30 min at 25 °C, water was added and the mixture was extracted with CH2Cl2 The combined organic layer was dried over MgSO4, filtered and concentrated under reduced pressure. The resulting mesylate was thoroughly dried and was taken up in 2 mL of DMF and 0.12 g (1.9 mmol) of sodium azide was added. The mixture was stirred at 45 °C for 15 h and then water was added. The solution was extracted with ether and the ether extracts were washed with brine. The organic layer was dried over MgSO4, filtered and concentrated under reduced pressure. The crude azide was subjected to flash silica gel chromatography to give 0.47 g (93%) of azide 53 as a yellow oil; IR (thin film) 2951, 2108, 1739, and 1315 cm−1;1H-NMR (CDCl3, 400 MHz) δ 1.96 (p, 2H, J = 7.2 Hz), 2.82 (t, 2H, J = 7.2 Hz), 3.33 (t, 2H, J = 6.8 Hz), 3.87 (s, 3H), and 7.12 (s, 1H); 13C-NMR (CDCl3, 100 MHz) δ 23.8, 26.9, 50.6, 52.2, 98.8, 121.3, 143.2, 156.4, and 158.5; FAB HRMS Calcd. for [(C9H10BrN3O3)+Li+]: 294.0066. Found: 294.0070.
4-Bromo-5-[3-(3a-methyl-2-oxo-2,3,3a,4,5,6-hexahydroindol-1-yl)propyl]-furan-2-carboxylic Acid Methyl Ester (56)
To a solution of the above azide 53 (1.0 mmol) in xylene (5 mL) in a microwave reaction tube was added tributyl-phosphine (1.0 mmol). The mixture was stirred for 1 h at room temperature, the solvent was removed under reduced pressure and 5 mL of xylene was added to the initially formed iminophosphorane 54 and this was followed by the addition of keto acid 14 (1 mmol). The reaction mixture was subjected to microwave irradiation at 180 °C for 10 min. The solution was concentrated under reduced pressure and the crude mixture was chromatographed on a silica gel column to give hexahydroindolinone 56 (63%) as a colorless oil;1H-NMR (300 MHz, CDCl3) δ 1.19 (s, 3H), 1.52 (m, 1H), 1.76–2.20 (m, 7H), 2.25 (s, 2H), 2.72 (t, 2H, J = 7.8 Hz), 3.24 (m, 1H), 3.68 (m, 1H), 3.87 (s, 3H), 4.74 (t, 1H, J = 3.6 Hz), and 7.10 (s, 1H); 13C-NMR (75 MHz, CDCl3) δ 18.5, 22.8, 24.3, 24.8, 26.3, 34.1, 36.4, 38.5, 46.4, 52.2, 97.5, 98.4, 121.4, 143.0, 145.5, 156.9, 158.5, and 174.0; HRMS Calcd. for C18H22BrNO4: 395.0733. Found: 395.0742
7-Carbomethoxy-7-(2-ethoxy-2-oxoethyl)-1,4-dioxaspiro[4,5]decan-8-one(57)
To a solution of 2.8 g (70 mmol) of NaH (60% in mineral oil) in 200 mL of THF at 0°C was added 10 g (64 mmol) of 1,4-dioxaspiro[4,5]decan-8-one (62) under N2 and the mixture was stirred vigorously for 30 min. The cold bath was removed and dimethyl carbonate (5.4 mL, 64 mmol) was added dropwise. Upon complete addition, the solution was placed in an oil bath and heated at reflux for 24 h. A saturated NH4Cl solution was then added and the reaction mixture was extracted with EtOAc. The combined organic layer was dried over MgSO4, filtered and concentrated under reduced pressure. Purification of the crude product using flash silica gel chromatography gave 6.3 g (48%) of the enol tautomer of 7-carbomethoxy-8-hydroxy-1,4-dioxaspiro[4,5]decan-7-ene;1H-NMR (CDCl3, 400 MHz) δ 1.79 (t, 2H, J = 7.2 Hz), 2.41 (s, 2H), 2.45 (tt, 2H, J = 7.2 and 1.2 Hz), 3.69 (s, 3H), 3.92–3.98 (m, 4H) and 12.10 (s, 1H). This compound was used in the next step without any further purification.
To a solution of 0.3 g (7.5 mmol) of NaH (60% in mineral oil) in 30 mL of THF at 0°C was added 1.3 g (6.2 mmol) of the above compound under N2 and the mixture was stirred for 30 min. The cold bath was removed and ethyl bromo-acetate (0.9 mL, 8.1 mmol) was added dropwise. The solution was stirred at 25 °C for 2 h. Water was added and the solution was extracted with EtOAc. The combined organic layer was dried over MgSO4, filtered and concentrated under reduced pressure. The crude mixture was subjected to flash silica gel chromatography to give 1.5 g (81%) of 57 as a colorless oil; IR (neat) 1730, 1717, 1375, 1305, 1195, 1167, 1136 and 1033 cm−1; 1H-NMR (400 MHz, CDCl3) δ 1.21 (t, 3H, J= 7.2 Hz), 1.94–2.09 (m, 2H), 2.12 (d, 1H, J= 13.6 Hz), 2.49 (d, 1H, J= 16.4 Hz), 2.52 (d, 1H, J= 14.0 Hz), 2.48–2.55 (m, 1H), 2.77 (d, 1H, J= 16.0 Hz), 3.08 (ddd, 1 H, J= 15.2, 13.2 and 7.2 Hz), 3.73 (s, 3H), 3.88–4.01 (m, 4H) and 4.08 (dq, 2H, J= 7.2 and 2.8); 13C-NMR (100 MHz, CDCl3) δ 14.2, 34.7, 37.5, 39.7, 42.0, 52.9, 56.7, 60.8, 64.6, 65.0, 106.6, 170.5, 172.5 and 205.9.
Methyl 1 -(3-(5-methylfuran-2-yl)propyl)-5,5-(1 -oxa-4-oxa butylene)-2,3,3a,4,5,6-hexahydro-1H-indole-2-one-3a-carboxylate (58)
To a solution of 0.35 g (1.2 mmol) of diester 57 in 2 mL of xylene in a microwave reaction tube was added 0.24 g (1.8 mmol) of 3-(5-methylfuran-2-yl)propan-1-amine (22). The vessel was sealed and subjected to microwave irradiation at 180 °C for 20 min. After removal of the solvent under reduced pressure, the crude residue was purified by flash silica gel chromatography to give 0.24 g (55%) of 58 as a colorless oil; IR (neat) 1726, 1677, 1406, 1311, 1288, 1170, 1139 and 1118 cm−1;1H-NMR (400 MHz, CDCl3) δ 1.74 (d, 1H, J= 13.2 Hz), 1.88–2.00 (m, 2H), 2.23 (d, 3H, J=0.8 Hz), 2.48–2.53 (m, 1H), 2.62 (q, 2H, J= 7.6 Hz), 2.55–2.71 (m, 2H), 2.75 (dd, 1H, J=13.2 and 1.2 Hz), 3.22–3.28 (m, 1H), 3.66 (s, 3H), 3.80 (dt, 1H, J= 14.0 and 7.6 Hz), 3.84–3.91 (m, 1H), 3.92–4.00 (m, 4H), 4.96 (t, 1H, J= 3.6 Hz), 5.83 (dd, 1H, J= 2.8 and 0.8 Hz) and 5.88 (d, 1H, J= 2.8 Hz); 13C-NMR (100 MHz, CDCl3) δ 13.7, 25.3, 25.7, 35.3, 39.3, 39.4, 42.9, 48.6, 52.9, 64.7, 64.8, 97.7, 106.1, 107.4, 139.3, 150.6, 153.4, 172.1 and 174.6; HRMS Calcd. for C20H25NO6 [M+H+]: 376.1715. Found: 376.1757.
Methyl 1 -(4,7-dioxooctyl)-2,5-dioxo-2,3,3a,4,5,6-hexahydro-1 H-indole-3a-carboxylate (60)
To a solution of 0.13 g (0.36 mmol) of tetrahydroindolinone 58 in 7 mL of CH2Cl2 was added trifluoroacetic acid (82 μL, 1.1 mmol). The mixture was stirred at rt for 24 h and then heated at reflux for another 24 h. The solvent was removed under reduced pressure and the crude product was purified by flash silica gel chromatography to give 0.08 g (67%) of a pale yellow oil which was identified as methyl 1 -(4,7-dioxooctyl)-2,5-dioxo-2,3,3a,-4,5,6-hexahydro-1 H-indole-3a-carboxylate (60) on the basis of its spectral data; IR (neat) 1719, 1678, 1609, 1411, 1367 and 1225 cm−1; 1H-NMR (400 MHz, CDCl3) δ 1.73–1.82 (m, 1 H), 1.84–1.90 (m, 1H), 2.17 (s, 3H), 2.42 (d, 1H, J=16.2 Hz), 2.46 (d, 1H, J= 16.8 Hz), 2.46–2.57 (m, 2H), 2.59–2.78 (m, 4H), 2.96–3.12 (m, 2H), 3.04 (dd, 2H, J=16.8 and 8.4 Hz), 3.36 (ddd, 1H, J= 14.4, 7.8 and 6.0 Hz), 3.65 (dt, 1H, J= 14.4 and 7.8 Hz), 3.72 (s, 3H) and 5.17 (dd, 1 H, J= 6.6 and 2.4 Hz); 13C-NMR (100 MHz, CDCl3) δ 20.4, 30.1, 36.3, 37.0, 37.2, 39.2, 39.3, 40.1, 46.4, 47.6, 53.5, 95.7, 140.1, 171.8, 173.1, 205.7, 207.4 and 208.7; HRMS Calcd. For C18H23NO6 [M+H+]: 350.1604. Found: 350.1596.
The minor fraction isolated from the column contained 0.01 g (11%) of methyl 1 -(3-(5-methylfuran-2-yl)propyl)-2,5-dioxo-2,3,3a,4,5,6-hexahydro-1H-indole-3a-carboxylate (61) as a pale yellow oil; IR (neat) 1731, 1614, 1414, 1209, 1177 and 735 cm−1; 1H-NMR (400 MHz, CDCl3) δ 1.83–1.93 (m, 2H), 2.23 (s, 3H), 2.40 (d, 1H, J= 16.4 Hz), 2.46 (d, 1H, J= 16.8 Hz), 2.59 (t, 2H, J=7.6 Hz), 2.92–3.14 (m, 4H), 3.35–3.42 (m, 1H), 3.71 (s, 3H), 3.69–3.76 (m, 1H), 5.02 (dd, 1H, J=6.0 and 2.4 Hz), 5.84 (s, 1H) and 5.87 (d, 1H, J=2.4 Hz); 13C-NMR (100 MHz, CDCl3) δ 13.7, 25.1, 25.4, 37.0, 39.6, 40.1, 46.4, 47.6, 53.5, 95.4, 106.1, 106.2, 140.3, 150.7, 153.0, 171.7, 173.1 and 205.7; HRMS Calcd. for C18H21NO5[M+H+]: 332.1498. Found: 332.1496.
7a-Hydroxy-1-(3-(5-methylfuran-2-yl)propyl)-5,5-(1-oxa-4-oxa-butylene)-hexahydro-1 H-indol-2(3H)-one (64)
To a solution of 1.8 mmol lithium diisopropylamine in 60 mL of THF at −78 °C was added a dropwise solution of 0.2 g (1.4 mmol) of 1,4-dioxaspiro[4,5]decan-8-one (62) in 11 mL of THF under N2. The mixture was stirred at −78 °C for 30 min and then a solution of 0.4 g (1.2 mmol) of 2-iodo-N-(3-(5-methylfuran-2-yl)propyl)acetamide (63) in 14 mL of THF was added dropwise to the reaction mixture over a 3 min interval. The solution was stirred for an additional 5 min at −78 °C and was allowed to warm to rt over 30 min. The reaction mixture was quenched with water and extracted with CH2Cl2- The organic layer was dried over Na2SO4 and concentrated under reduced pressure. The crude reaction mixture was purified by flash silica gel chromatography to give 0.27 g (70%) of 64 as a colorless oil; IR (neat) 3354, 1671, 1570, 1433, 1368, 1125, 1023 and 785 cm−1;1H-NMR (400 MHz, CDCl3) δ 1.41 (dd, 1H, J= 14.0 and 8.4 Hz), 1.50 (ddd, 1H, J= 13.6, 9.6 and 3.6 Hz), 1.66–1.72 (m, 1H), 1.76–1.96 (m, 4H), 2.03 (ddd, 1H, J= 14.4, 9.6 and 4.0 Hz), 2.13 (dd, 1H, J= 16.4 and 5.2 Hz), 2.18 (s, 3H), 2.29–2.36 (m, 1H), 2.53–2.60 (m, 3H), 3.12 (ddd, 1H, J= 14.0, 9.6 and 6.4 Hz), 3.30 (ddd, 1H, J= 14.0, 9.6 and 5.6 Hz), 3.88 (s, 4H), 4.24 (brs, 1H), 5.77 (dd, 1H) and 5.82 (d, 1H, J= 3.2 Hz); 13C-NMR (100 MHz, CDCl3) δ 13.6, 25.9, 27.8, 30.7, 31.0, 36.1, 36.2, 38.6, 40.7, 64.3, 64.4, 89.9, 105.7, 106.0, 107.9, 150.3, 153.5 and 175.3; HRMS Calcd. for C18H25NO5 [M+H+]: 336.1812. Found: 336.1806.
1,2-Furanyl Fused Octahydroazepino[1,2-i]indole-7,10(1H,8H)-dione (65)
To a solution of 0.2 g (0.72 mmol) of aminol 64 in 7 mL of CH2Cl2 at 0 °C was added trifluoroacetic acid (0.11 mL, 1.4 mmol). The reaction mixture was stirred at rt for 24 h and then a saturated NaHCO3 solution was added and the resulting mixture was extracted with CH2Cl2- The combined organic layer was washed with a saturated NaHCO3 solution, dried over Na2SO4 and concentrated under reduced pressure. The crude mixture was purified by flash silica gel chromatography to give 0.06 g (30%) of 65 as a pale yellow oil); IR (neat) 1716, 1678, 1407, 1269 and 730 cm−1; 1H-NMR (400 MHz, CDCl3) δ 1.87–1.95 (m, 2H), 2.04 (dd, 1H, J = 17.6 and 4.0 Hz), 2.13–2.30 (m, 3H), 2.20 (s, 3H), 2.32–2.36 (m, 1H), 2.40 (d, 1H, J= 15.6 and 7.2 Hz), 2.62–2.72 (m, 2H), 2.78 (ddd, 1H, J= 14.4, 9.2 and 5.6 Hz), 2.84–2.97 (m, 3H), 4.30 (dt, 1H, J= 14.4 and 4.8 Hz) and 5.81 (s, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.5, 25.4, 26.8, 32.2, 35.4, 37.1, 37.2, 39.9, 43.2, 62.6, 104.9, 126.6, 149.1, 150.3, 173.4 and 210.2; HRMS Calcd. for C16H19NO3 [M+H+]: 274.1444. Found: 274.1440.
The other minor compound that was isolated from the chromatographic column consisted of 0.02 g (9%) of the corresponding ketal of 65 as a colorless oil; 1H-NMR (400 MHz, CDCl3) δ 1.49 (dd, 1H, J= 13.6 and 12.0 Hz), 1.51 (td, 1H, J= 13.6 and 4.0 Hz), 1.63 (ddd, 1H, J= 13.2, 6.4 and 4.0 Hz), 1.78 (ddd, 1H, J= 13.6, 6.4 and 2.8 Hz), 1.82–1.88 (m, 1H), 1.92 (d, 1H, J= 16.0 Hz), 1.96–2.06 (m, 2H), 2.15 (dt, 1H, J= 15.2 and 4.0 Hz), 2.18 (s, 3H), 2.42 (dd, 1H, J= 16.0 and 6.8 Hz), 2.55–2.61 (m, 1H), 2.66 (dd, 2H, J= 6.0 and 5.6 Hz), 2.99 (dt, 1H, J= 14.4 and 5.6 Hz), 3.90–4.00 (m, 4H), 4.31 (ddd, 1H, J= 14.4, 8.8 and 6.0 Hz) and 5.85 (s, 1H); 13C-NMR (100 MHz, CDCl3) δ 13.6, 25.7, 26.1, 30.5, 31.2, 37.1, 37.5, 38.1, 38.9, 62.1, 64.5, 64.7, 105.3, 107.7, 126.6, 149.6, 150.8 and 176.0.
Supplementary Material
Supporting Information Available: 1H and 13C NMR data of various key compounds lacking CHN analyses. This material is available free of charge via the Internet at http://pubs.acs.org.
Figure 1.
Representative Erythrinan and Homoerythrinan Alkaloids
Scheme 1.
Pictet-Spengler Cyclization
Acknowledgments
This research was supported by the National Institutes of Health (GM 0539384) and the National Science Foundation (CHE-0450779). MDR wishes to express her appreciation to the NIH for a Ruth L. Kirchstein Predoctoral Fellowship. We wish to thank Dr. Ayse Daut Ozdemir for some preliminary experiments in developing the aza-Wittig reactions used to prepare the starting furanyl substituted tetrahydroindolinones.
References and Notes
- 1.Pictet A, Spengler T. Ber Dtsch Chem Ges. 1911;44:2030. [Google Scholar]
- 2.Decker H, Becker P. Justus Liebigs Ann Chem. 1913;395:342. [Google Scholar]
- 3.For reviews, see: Czerwinski KM, Cook JM. Adv Heterocycl Nat Prod Synth. 1996;3:217.Cox ED, Cook JM. Chem Rev. 1995;95:1797.Waldmann H. Synlett. 1995:133.Rozwadowska MD. Heterocycles. 1994;39:903.Badia D, Dominguez E, Lete E, Villa MJ. Trends Heterocycl Chem. 1991;2:1.Ungemach F, Cook JM. Heterocycles. 1978;9:1089.Claret PA. In: Comprehensive Organic Chemistry. Barton D, Ollis WE, editors. Vol. 4. Pergomon; Oxford: 1979. p. 209.Gensler WJ. In: Heterocyclic Compounds. Elderfield RC, editor. Vol. 4. Wiley; New York: 1952. p. 353.Whaley WM, Govindachari TR. Org React. 1951;6:151.
- 4.(a) Brown RT. In: Indoles. Saxton JE, editor. Wiley-lnterscience; New York: 1983. Part 4. [Google Scholar]; (b) Bentley KW. Nat Prod Rep. 2004;21:395. doi: 10.1039/b212259f. and references cited therein. [DOI] [PubMed] [Google Scholar]
- 5.Strong Brönsted acids are most commonly employed to promote the Pictet-Spengler reaction, see: Dunetz JR, Ciccolini RP, Fröling M, Paap SM, Allen AJ, Holmes AB, Tester JW, Danheiser RL. Chem Commun. 2005:4465. doi: 10.1039/b508151c.Nakamura S, Tanaka M, Taniguchi T, Uchiyama M, Ohwada T. Org Lett. 2003;5:2087. doi: 10.1021/ol034526a.Kuo F-M, Tseng M-C, Yen Y-H, Chu Y-H. Tetrahedron. 2004;60:12075.
- 6.Yokoyama A, Ohwada T, Shudo K. J Org Chem. 1999;64:611. [Google Scholar]
- 7.(a) Cox ED, Hamaker LK, Li J, Yu P, Czerwinski KM, Deng L, Bennett DW, Cook JM. J Org Chem. 1997;62:44. doi: 10.1021/jo951170a. [DOI] [PubMed] [Google Scholar]; (b) Czarnocki Z, MacLean DB, Szarek WA. Can J Chem. 1986;64:2205. [Google Scholar]; (c) Czarnocki Z, Suh D, MacLean DB, Hultin PG, Szarek WA. Can J Chem. 1992;70:1555. [Google Scholar]; (d) Czarnocki Z, Mieczkowsi JB, Kiegiel J, Arazny Z. Tetrahedron: Asymmetry. 1995;6:2899. [Google Scholar]; (e) Waldmann H, Schmidt G, Henke H, Burkard M. Angew Chem Int Ed Engl. 1995;34:2402. [Google Scholar]; (f) Schmidt G, Waldmann H, Hanke H, Burkard M. Chem Eur J. 1996;2:1566. [Google Scholar]; (g) Gremmen C, Willemse B, Wanner MJ, Koomen G-J. Org Lett. 2000;2:1955. doi: 10.1021/ol006034t. [DOI] [PubMed] [Google Scholar]; (h) Gremmen C, Wanner MJ, Koomen G-J. Tetrahedron Lett. 2001;42:8885. [Google Scholar]; (i) Tsuji R, Nakagawa M, Nishida A. Tetrahedron:Asymmetry. 2003;14:177. [Google Scholar]
- 8.Taylor MS, Jacobsen EN. J Am Chem Soc. 2004;126:10558. doi: 10.1021/ja046259p. [DOI] [PubMed] [Google Scholar]
- 9.Seayad J, Seayad AM, List B. J Am Chem Soc. 2006;128:1086. doi: 10.1021/ja057444l. [DOI] [PubMed] [Google Scholar]
- 10.(a) Lee HI, Cassidy MP, Rashatasakhon P, Padwa A. Org Lett. 2003;5:5067. doi: 10.1021/ol036106r. [DOI] [PubMed] [Google Scholar]; (b) Padwa A, Lee HI, Rashatasakhon P, Rose M. J Org Chem. 2004;69:8209. doi: 10.1021/jo048647f. [DOI] [PubMed] [Google Scholar]; (c) Cassidy MP, Özdemir AD, Padwa A. Org Lett. 2005;7:1339. doi: 10.1021/ol0501323. [DOI] [PubMed] [Google Scholar]
- 11.(a) Dyke SF, Quessy SN. In: The Alkaloids. Rodrigo RGA, editor. Vol. 18. Academic Press; New York: 1981. pp. 1–98. [Google Scholar]; (b) Chawla AS, Kapoor VK. In: The Alkaloids: Chemical and Biological Perspectives. Pelletier SW, editor. Vol. 9. Pergamon; 1995. pp. 86–153. [Google Scholar]
- 12.Deulofeu V. In: Curare and Curarelike Agents. Bovet D, Bovet-Nitti F, Marini-Bettolo GB, editors. Elsevier; Amsterdam: 1959. p. 163. [Google Scholar]
- 13.Tsuda Y, Sano T. In: The Alkaloids. Cordell GA, editor. Vol. 48. Academic Press; San Diego: 1996. pp. 249–337. [Google Scholar]
- 14.Kawasaki T, Onoda N, Watanabe H, Kitahara T. Tetrahedron Lett. 2001;42:8003. [Google Scholar]
- 15.(a) Wang Q, Padwa A. Org Lett. 2006;8:601. doi: 10.1021/ol0527330. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Kim G, Kim JH, Lee KY. J Org Chem. 2006;71:2185. doi: 10.1021/jo052500m. [DOI] [PubMed] [Google Scholar]; (c) Parsons AF, Williams DA. Tetrahedron. 2000;56:7217. [Google Scholar]; (d) Belleau B. J Am Chem Soc. 1953;75:5765. [Google Scholar]; (e) Mondon A, Hansen KF. Tetrahedron Lett. 1960;1:5. [Google Scholar]; (f) Ishibashi H, Sato T, Takahashi M, Hayashi M, Ikeda M. Heterocycles. 1988;27:2787. [Google Scholar]; (g) Tsuda Y, Hosoi S, Ishida K, Sangai M. Chem Pharm Bull. 1994;42:204. [Google Scholar]; (h) Cassayre J, Quiclet-Sire B, Saunier J-B, Zard SZ. Tetrahedron Lett. 1998;39:8995. [Google Scholar]; (i) Rigby JH, Deur C, Heeg MJ. Tetrahedron Lett. 1999;40:6887. [Google Scholar]; (j) Toyao A, Chikaoka S, Takeda Y, Tamura O, Muraoka O, Tanabe G, Ishibashi H. Tetrahedron Lett. 2001;42:1729. [Google Scholar]; (k) Miranda LD, Zard SZ. Org Lett. 2002;4:1135. doi: 10.1021/ol025534e. [DOI] [PubMed] [Google Scholar]; (I) Allin SM, James SL, Elsegood MRJ, Martin WP. J Org Chem. 2002;67:9464. doi: 10.1021/jo0205661. [DOI] [PubMed] [Google Scholar]; (m) Toda J, Niimurea Y, Takeda K, Sano T, Tsuda Y. Chem Pharm Bull. 1998;46:906. [Google Scholar]; (n) Jousse C, Demaële D. Eur J Org Chem. 1999:909. [Google Scholar]
- 16.(a) Danishefsky SJ, Panek JS. J Am Chem Soc. 1987;109:917. [Google Scholar]; (b) Ahmed-Schofield R, Mariano PS. J Org Chem. 1987;52:1478. [Google Scholar]; (c) Irie H, Shibata K, Matsuno K, Zhang Y. Heterocycles. 1989;29:1033. [Google Scholar]; (d) Kawasaki T, Onoda N, Watanabe H, Kitahara T. Tetrahedron Lett. 2001;42:8003. [Google Scholar]
- 17.(a) Wasserman HH, Amici RM. J Org Chem. 1989;54:5843. [Google Scholar]; (b) Sano T, Toda J, Kashiwaba N, Ohshima T, Tsuda Y. Chem Pharm Bull. 1987;35:479. [Google Scholar]; (c) Tsuda Y, Hosoi S, Katagiri N, Kaneko C, Sano T. Heterocycles. 1992;33:497. [Google Scholar]
- 18.(a) Curtis WM. The Student’s Flora of Tasmania, Part 1. Tasmanian Government Printer; Hobart: 1956. p. 6. [Google Scholar]; (b) Bick IRC, Bremner JB, Razak A, Thuc LV. Experientia. 1980;36:1135. [Google Scholar]; (c) Panichanun S, Bick IRC. Tetrahedron. 1984;40:2685. [Google Scholar]
- 19.For some earlier examples of furan-terminated N-acyliminium ion initiated cyclizations, see: Tanis SP, Deaton MV, Dixon LA, McMills MC, Raggon JW, Collins MA. J Org Chem. 1998;63:6914. doi: 10.1021/jo980718l.
- 20.Maryanoff BE, Zhang HC, Cohen JH, Turchi IJ, Maryanoff CA. Chem Rev. 2004;104:1431. doi: 10.1021/cr0306182. [DOI] [PubMed] [Google Scholar]
- 21.(a) Wilkens HJ, Traxler F. Helv Chim Acta. 1975;58:1512. [Google Scholar]; (b) Mondon A, Hansen KF, Boehme K, Faro HP, Nestler HJ, Vilhuber HG, Böttcher K. Chem Ber. 1970;103:615. [Google Scholar]; (c) Mondon A, Nestler HJ. Chem Ber. 1979;112:1329. [Google Scholar]; (d) Dean RT, Rapoport HA. J Org Chem. 1978;43:4183. [Google Scholar]
- 22.The β-erythroidine skeleton has been prepared by an oxidative degradation of the aromatic ring (ring A) in erythrinas as the key step; see: Isobe K, Mohri K, Itoh Y, Toyokawa Y, Takeda N, Taga J, Hosoi S, Tsuda Y. Chem Pharm Bull. 1992;40:2632.
- 23.Bentley KW. Nat Prod Rep. 2001;18:148. doi: 10.1039/a909672h. [DOI] [PubMed] [Google Scholar]
- 24.Staudinger H, Meyer J. Helv Chim Acta. 1919;2:635. [Google Scholar]
- 25.(a) Wamhoff H, Richardt G, Stölben S. Adv Heterocycl Chem. 1995;64:159. [Google Scholar]; (b) Eguchi S, Matsushita Y, Yamashita K. Org Prep Proced Int. 1992;24:209. [Google Scholar]; (c) Barluenga J, Palacios F. Org Prep Proced Int. 1991;23:1. [Google Scholar]; (d) Fresneda PM, Molina P. Synlett. 2004:1. [Google Scholar]
- 26.(a) Molina P, Vilaplana MJ. Synthesis. 1994:1917. [Google Scholar]; (b) Gusari NI. Russ Chem Rev (Engl Transl) 1991;60:146. [Google Scholar]
- 27.Padwa A, Gunn DE, Osterhout MH. Synthesis. 1997:1353. [Google Scholar]
- 28.(a) Padwa A, Hennig R, Kappe CO, Reger TS. J Org Chem. 1998;63:1144. [Google Scholar]; (b) Padwa A, Kappe CO, Reger TS. J Org Chem. 1996;61:4888. [Google Scholar]; (c) Padwa A, Heidelbaugh TM, Kuethe JT, McClure MS. J Org Chem. 1998;63:6778. doi: 10.1021/jo981349w. [DOI] [PubMed] [Google Scholar]
- 29.Padwa A, Heidelbaugh TM, Kuethe JT, McClure MS, Wang Q. J Org Chem. 2002;67:5928. doi: 10.1021/jo020083x. [DOI] [PubMed] [Google Scholar]
- 30.Denmark SE. In: Comprehensive Organic Synthesis. Trost BM, Fleming I, editors. Vol. 5. Pergamon Press; Oxford: 1991. pp. 751–784. [Google Scholar]
- 31.While our studies were in progress, a related report appeared in the literature, see: Gao S, Tu YQ, Hu X, Wang S, Hua R, Jiang Y, Zhao Y, Fan X, Zhang S. Org Lett. 2006;8:2373. doi: 10.1021/ol0607185.
- 32.Asselin AA, Number LG, Dobson TA, Komlossy J, Martel RR. J Med Chem. 1976;19:787. doi: 10.1021/jm00228a010. [DOI] [PubMed] [Google Scholar]
- 33.Jung ME, Miller SJ. Heterocycles. 1990;30:839. [Google Scholar]
- 34.Sorm F, Brandejs J. Coll Czec Chem Comm. 1947;12:444. [Google Scholar]
- 35.Pleninger H, Castro CE. Chem Ber. 1954;87:1760. [Google Scholar]
- 36.Shuikin NI, Petrov AD, Glukhovtsev VG, Bel’skii IF, Skobtsova GE. Isvestiya Akademii Nauk SSSR, Seriya Khim. 1964;9:1682. [Google Scholar]
- 37.Wedler C, Schick H. J Prakt Chem. 1993;335:410. [Google Scholar]
- 38.Kel’in AV, Gevorgyan V. J Org Chem. 2002;67:95. doi: 10.1021/jo010832v. [DOI] [PubMed] [Google Scholar]
- 39.López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Fowler CJ, Tiger G, de Lago E, Fernández-Ruiz J, Ramos JA. J Med Chem. 2003;46:1512. doi: 10.1021/jm0210818. [DOI] [PubMed] [Google Scholar]
- 40.Herz W. J Am Chem Soc. 1953;75:483. [Google Scholar]
- 41.Snieckus V, Bhandari KS. Tetrahedron Lett. 1969;39:3375. [Google Scholar]
- 42.Chadwick DJ, Chambers J, Meakins GD, Snowden RL. J Chem Soc, Perkin Trans 1. 1973:1766. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting Information Available: 1H and 13C NMR data of various key compounds lacking CHN analyses. This material is available free of charge via the Internet at http://pubs.acs.org.